KR102431821B1 - A beverage composition comprising oil, maltodextrin and pectin and manufacturing method thereof - Google Patents
A beverage composition comprising oil, maltodextrin and pectin and manufacturing method thereof Download PDFInfo
- Publication number
- KR102431821B1 KR102431821B1 KR1020210161588A KR20210161588A KR102431821B1 KR 102431821 B1 KR102431821 B1 KR 102431821B1 KR 1020210161588 A KR1020210161588 A KR 1020210161588A KR 20210161588 A KR20210161588 A KR 20210161588A KR 102431821 B1 KR102431821 B1 KR 102431821B1
- Authority
- KR
- South Korea
- Prior art keywords
- oil
- maltodextrin
- pectin
- beverage composition
- weight
- Prior art date
Links
- 239000003921 oil Substances 0.000 title claims abstract description 108
- 229920002774 Maltodextrin Polymers 0.000 title claims abstract description 101
- 239000005913 Maltodextrin Substances 0.000 title claims abstract description 100
- 229940035034 maltodextrin Drugs 0.000 title claims abstract description 100
- 239000000203 mixture Substances 0.000 title claims abstract description 100
- 239000001814 pectin Substances 0.000 title claims abstract description 58
- 229920001277 pectin Polymers 0.000 title claims abstract description 58
- 235000010987 pectin Nutrition 0.000 title claims abstract description 58
- 235000013361 beverage Nutrition 0.000 title claims abstract description 40
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 17
- 239000003995 emulsifying agent Substances 0.000 claims abstract description 16
- 239000000084 colloidal system Substances 0.000 claims abstract description 10
- 230000001681 protective effect Effects 0.000 claims abstract description 10
- 239000000126 substance Substances 0.000 claims abstract description 7
- 230000000975 bioactive effect Effects 0.000 claims abstract description 6
- 235000019198 oils Nutrition 0.000 claims description 104
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 claims description 60
- 235000017471 coenzyme Q10 Nutrition 0.000 claims description 60
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical group COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 claims description 59
- 229940110767 coenzyme Q10 Drugs 0.000 claims description 58
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 26
- 238000000034 method Methods 0.000 claims description 22
- 229940106134 krill oil Drugs 0.000 claims description 17
- 239000006185 dispersion Substances 0.000 claims description 16
- 239000013543 active substance Substances 0.000 claims description 14
- 239000000243 solution Substances 0.000 claims description 11
- 239000007864 aqueous solution Substances 0.000 claims description 9
- -1 omega 3 Natural products 0.000 claims description 8
- 239000002562 thickening agent Substances 0.000 claims description 8
- 239000010478 argan oil Substances 0.000 claims description 7
- 239000001913 cellulose Substances 0.000 claims description 7
- 229920002678 cellulose Polymers 0.000 claims description 7
- 239000008157 edible vegetable oil Substances 0.000 claims description 7
- JBYXPOFIGCOSSB-GOJKSUSPSA-N 9-cis,11-trans-octadecadienoic acid Chemical compound CCCCCC\C=C\C=C/CCCCCCCC(O)=O JBYXPOFIGCOSSB-GOJKSUSPSA-N 0.000 claims description 6
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 6
- 229940108924 conjugated linoleic acid Drugs 0.000 claims description 6
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 claims description 6
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 claims description 6
- CNNRPFQICPFDPO-UHFFFAOYSA-N octacosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCO CNNRPFQICPFDPO-UHFFFAOYSA-N 0.000 claims description 6
- 229920000161 Locust bean gum Polymers 0.000 claims description 5
- 235000010420 locust bean gum Nutrition 0.000 claims description 5
- 239000000711 locust bean gum Substances 0.000 claims description 5
- 235000017807 phytochemicals Nutrition 0.000 claims description 5
- 229930000223 plant secondary metabolite Natural products 0.000 claims description 5
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 5
- 235000019485 Safflower oil Nutrition 0.000 claims description 4
- 239000010775 animal oil Substances 0.000 claims description 4
- 239000003346 palm kernel oil Substances 0.000 claims description 4
- 235000019865 palm kernel oil Nutrition 0.000 claims description 4
- 235000005713 safflower oil Nutrition 0.000 claims description 4
- 239000003813 safflower oil Substances 0.000 claims description 4
- 239000008158 vegetable oil Substances 0.000 claims description 4
- 229960002666 1-octacosanol Drugs 0.000 claims description 3
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 3
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 claims description 3
- 235000013793 astaxanthin Nutrition 0.000 claims description 3
- 229940022405 astaxanthin Drugs 0.000 claims description 3
- 239000001168 astaxanthin Substances 0.000 claims description 3
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 3
- 235000021323 fish oil Nutrition 0.000 claims description 3
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 claims description 3
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 claims description 3
- 235000020664 gamma-linolenic acid Nutrition 0.000 claims description 3
- 229960002733 gamolenic acid Drugs 0.000 claims description 3
- 235000012680 lutein Nutrition 0.000 claims description 3
- 239000001656 lutein Substances 0.000 claims description 3
- 229960005375 lutein Drugs 0.000 claims description 3
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 claims description 3
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 claims description 3
- 239000002540 palm oil Substances 0.000 claims description 3
- 235000020944 retinol Nutrition 0.000 claims description 3
- 229960003471 retinol Drugs 0.000 claims description 3
- 239000011607 retinol Substances 0.000 claims description 3
- 235000010384 tocopherol Nutrition 0.000 claims description 3
- 229960001295 tocopherol Drugs 0.000 claims description 3
- 229930003799 tocopherol Natural products 0.000 claims description 3
- 239000011732 tocopherol Substances 0.000 claims description 3
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 claims description 3
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 claims description 3
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims description 3
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 claims description 2
- 244000215068 Acacia senegal Species 0.000 claims description 2
- 229920001817 Agar Polymers 0.000 claims description 2
- 235000019489 Almond oil Nutrition 0.000 claims description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 2
- 235000013912 Ceratonia siliqua Nutrition 0.000 claims description 2
- 240000008886 Ceratonia siliqua Species 0.000 claims description 2
- 102000002322 Egg Proteins Human genes 0.000 claims description 2
- 108010000912 Egg Proteins Proteins 0.000 claims description 2
- 239000001188 FEMA 4487 Substances 0.000 claims description 2
- 241000287828 Gallus gallus Species 0.000 claims description 2
- 108010010803 Gelatin Proteins 0.000 claims description 2
- 229920002148 Gellan gum Polymers 0.000 claims description 2
- 229920002907 Guar gum Polymers 0.000 claims description 2
- 229920000084 Gum arabic Polymers 0.000 claims description 2
- 235000019487 Hazelnut oil Nutrition 0.000 claims description 2
- 229920002488 Hemicellulose Polymers 0.000 claims description 2
- 241000772415 Neovison vison Species 0.000 claims description 2
- 235000019482 Palm oil Nutrition 0.000 claims description 2
- 235000019483 Peanut oil Nutrition 0.000 claims description 2
- 235000009827 Prunus armeniaca Nutrition 0.000 claims description 2
- 244000018633 Prunus armeniaca Species 0.000 claims description 2
- 241000382353 Pupa Species 0.000 claims description 2
- 235000019484 Rapeseed oil Nutrition 0.000 claims description 2
- 235000019774 Rice Bran oil Nutrition 0.000 claims description 2
- 235000019486 Sunflower oil Nutrition 0.000 claims description 2
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 claims description 2
- 235000009470 Theobroma cacao Nutrition 0.000 claims description 2
- 244000299461 Theobroma cacao Species 0.000 claims description 2
- 235000019498 Walnut oil Nutrition 0.000 claims description 2
- 235000010489 acacia gum Nutrition 0.000 claims description 2
- 239000000205 acacia gum Substances 0.000 claims description 2
- 239000008272 agar Substances 0.000 claims description 2
- 235000010419 agar Nutrition 0.000 claims description 2
- 229920000615 alginic acid Polymers 0.000 claims description 2
- 235000010443 alginic acid Nutrition 0.000 claims description 2
- 239000000783 alginic acid Substances 0.000 claims description 2
- 229960001126 alginic acid Drugs 0.000 claims description 2
- 150000004781 alginic acids Chemical class 0.000 claims description 2
- 239000008168 almond oil Substances 0.000 claims description 2
- 239000010476 amaranth oil Substances 0.000 claims description 2
- 239000010479 artichoke oil Substances 0.000 claims description 2
- 235000021302 avocado oil Nutrition 0.000 claims description 2
- 239000008163 avocado oil Substances 0.000 claims description 2
- 235000015278 beef Nutrition 0.000 claims description 2
- 239000010481 ben oil Substances 0.000 claims description 2
- 235000021324 borage oil Nutrition 0.000 claims description 2
- 239000010482 borneo tallow nut oil Substances 0.000 claims description 2
- 239000010483 buffalo gourd oil Substances 0.000 claims description 2
- 235000019519 canola oil Nutrition 0.000 claims description 2
- 239000000828 canola oil Substances 0.000 claims description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims description 2
- 235000010418 carrageenan Nutrition 0.000 claims description 2
- 239000000679 carrageenan Substances 0.000 claims description 2
- 229920001525 carrageenan Polymers 0.000 claims description 2
- 229940113118 carrageenan Drugs 0.000 claims description 2
- 239000004359 castor oil Substances 0.000 claims description 2
- 235000019438 castor oil Nutrition 0.000 claims description 2
- 235000019864 coconut oil Nutrition 0.000 claims description 2
- 239000003240 coconut oil Substances 0.000 claims description 2
- 235000005687 corn oil Nutrition 0.000 claims description 2
- 239000002285 corn oil Substances 0.000 claims description 2
- 235000012343 cottonseed oil Nutrition 0.000 claims description 2
- 239000002385 cottonseed oil Substances 0.000 claims description 2
- 235000013399 edible fruits Nutrition 0.000 claims description 2
- 235000013345 egg yolk Nutrition 0.000 claims description 2
- 210000002969 egg yolk Anatomy 0.000 claims description 2
- 235000008524 evening primrose extract Nutrition 0.000 claims description 2
- 239000010475 evening primrose oil Substances 0.000 claims description 2
- 229940089020 evening primrose oil Drugs 0.000 claims description 2
- 239000008273 gelatin Substances 0.000 claims description 2
- 229920000159 gelatin Polymers 0.000 claims description 2
- 229940014259 gelatin Drugs 0.000 claims description 2
- 235000019322 gelatine Nutrition 0.000 claims description 2
- 235000011852 gelatine desserts Nutrition 0.000 claims description 2
- 235000010492 gellan gum Nutrition 0.000 claims description 2
- 239000000216 gellan gum Substances 0.000 claims description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims description 2
- 239000010503 gourd oil Substances 0.000 claims description 2
- 235000010417 guar gum Nutrition 0.000 claims description 2
- 239000000665 guar gum Substances 0.000 claims description 2
- 229960002154 guar gum Drugs 0.000 claims description 2
- 239000010468 hazelnut oil Substances 0.000 claims description 2
- 229940119170 jojoba wax Drugs 0.000 claims description 2
- 235000021388 linseed oil Nutrition 0.000 claims description 2
- 239000000944 linseed oil Substances 0.000 claims description 2
- 229920000609 methyl cellulose Polymers 0.000 claims description 2
- 239000001923 methylcellulose Substances 0.000 claims description 2
- 235000010981 methylcellulose Nutrition 0.000 claims description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 claims description 2
- 239000004533 oil dispersion Substances 0.000 claims description 2
- 235000008390 olive oil Nutrition 0.000 claims description 2
- 239000004006 olive oil Substances 0.000 claims description 2
- 239000000312 peanut oil Substances 0.000 claims description 2
- 239000010491 poppyseed oil Substances 0.000 claims description 2
- 239000008165 rice bran oil Substances 0.000 claims description 2
- 235000011803 sesame oil Nutrition 0.000 claims description 2
- 239000008159 sesame oil Substances 0.000 claims description 2
- 235000012424 soybean oil Nutrition 0.000 claims description 2
- 239000003549 soybean oil Substances 0.000 claims description 2
- 229940032094 squalane Drugs 0.000 claims description 2
- 229940031439 squalene Drugs 0.000 claims description 2
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 claims description 2
- 239000002600 sunflower oil Substances 0.000 claims description 2
- 239000003760 tallow Substances 0.000 claims description 2
- 239000008170 walnut oil Substances 0.000 claims description 2
- 229920001285 xanthan gum Polymers 0.000 claims description 2
- 235000010493 xanthan gum Nutrition 0.000 claims description 2
- 239000000230 xanthan gum Substances 0.000 claims description 2
- 229940082509 xanthan gum Drugs 0.000 claims description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 claims description 2
- 239000010480 babassu oil Substances 0.000 claims 1
- 238000009472 formulation Methods 0.000 abstract description 48
- 230000001954 sterilising effect Effects 0.000 abstract description 12
- 238000004659 sterilization and disinfection Methods 0.000 abstract description 12
- 230000000694 effects Effects 0.000 abstract description 8
- 239000013078 crystal Substances 0.000 abstract description 4
- 230000037406 food intake Effects 0.000 abstract description 4
- 238000001556 precipitation Methods 0.000 abstract description 4
- 230000015572 biosynthetic process Effects 0.000 abstract description 3
- 239000007791 liquid phase Substances 0.000 abstract description 3
- 239000000796 flavoring agent Substances 0.000 description 40
- 235000019634 flavors Nutrition 0.000 description 36
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 21
- 230000000052 comparative effect Effects 0.000 description 21
- 238000012360 testing method Methods 0.000 description 18
- 230000000087 stabilizing effect Effects 0.000 description 13
- 239000003765 sweetening agent Substances 0.000 description 13
- 238000003756 stirring Methods 0.000 description 12
- 235000013305 food Nutrition 0.000 description 11
- 235000003599 food sweetener Nutrition 0.000 description 11
- 235000000346 sugar Nutrition 0.000 description 11
- 239000002994 raw material Substances 0.000 description 10
- 239000000843 powder Substances 0.000 description 9
- 230000006641 stabilisation Effects 0.000 description 9
- 238000011105 stabilization Methods 0.000 description 9
- 238000002156 mixing Methods 0.000 description 8
- 239000008213 purified water Substances 0.000 description 8
- 238000000926 separation method Methods 0.000 description 8
- 239000012530 fluid Substances 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 5
- 239000012141 concentrate Substances 0.000 description 5
- 235000013376 functional food Nutrition 0.000 description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- 239000011149 active material Substances 0.000 description 4
- IAJILQKETJEXLJ-RSJOWCBRSA-N aldehydo-D-galacturonic acid Chemical group O=C[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-RSJOWCBRSA-N 0.000 description 4
- 239000003623 enhancer Substances 0.000 description 4
- 235000013355 food flavoring agent Nutrition 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- GRVDJDISBSALJP-UHFFFAOYSA-N methyloxidanyl Chemical group [O]C GRVDJDISBSALJP-UHFFFAOYSA-N 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- 229920001542 oligosaccharide Polymers 0.000 description 4
- 150000002482 oligosaccharides Chemical class 0.000 description 4
- 229920001282 polysaccharide Polymers 0.000 description 4
- 239000005017 polysaccharide Substances 0.000 description 4
- 150000004804 polysaccharides Chemical class 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 description 3
- 229940107187 fructooligosaccharide Drugs 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 235000013336 milk Nutrition 0.000 description 3
- 239000008267 milk Substances 0.000 description 3
- 210000004080 milk Anatomy 0.000 description 3
- 238000004904 shortening Methods 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000252203 Clupea harengus Species 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 2
- 240000003183 Manihot esculenta Species 0.000 description 2
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- 241001125048 Sardina Species 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 210000002421 cell wall Anatomy 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000005515 coenzyme Substances 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 238000004945 emulsification Methods 0.000 description 2
- 238000005538 encapsulation Methods 0.000 description 2
- 230000032050 esterification Effects 0.000 description 2
- 238000005886 esterification reaction Methods 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 235000019514 herring Nutrition 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- 239000002502 liposome Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000012263 liquid product Substances 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 210000003470 mitochondria Anatomy 0.000 description 2
- 150000002772 monosaccharides Chemical group 0.000 description 2
- 235000021096 natural sweeteners Nutrition 0.000 description 2
- 239000007968 orange flavor Substances 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000005180 public health Effects 0.000 description 2
- 235000019512 sardine Nutrition 0.000 description 2
- 238000004062 sedimentation Methods 0.000 description 2
- 235000021092 sugar substitutes Nutrition 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- OMDQUFIYNPYJFM-XKDAHURESA-N (2r,3r,4s,5r,6s)-2-(hydroxymethyl)-6-[[(2r,3s,4r,5s,6r)-4,5,6-trihydroxy-3-[(2s,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methoxy]oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@H](O)[C@H](O)O1 OMDQUFIYNPYJFM-XKDAHURESA-N 0.000 description 1
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- MIDXCONKKJTLDX-UHFFFAOYSA-N 3,5-dimethylcyclopentane-1,2-dione Chemical compound CC1CC(C)C(=O)C1=O MIDXCONKKJTLDX-UHFFFAOYSA-N 0.000 description 1
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 235000011437 Amygdalus communis Nutrition 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241001070941 Castanea Species 0.000 description 1
- 235000014036 Castanea Nutrition 0.000 description 1
- 241000238366 Cephalopoda Species 0.000 description 1
- 241000251730 Chondrichthyes Species 0.000 description 1
- 244000241235 Citrullus lanatus Species 0.000 description 1
- 235000012828 Citrullus lanatus var citroides Nutrition 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 241001454694 Clupeiformes Species 0.000 description 1
- 244000241257 Cucumis melo Species 0.000 description 1
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 241000723298 Dicentrarchus labrax Species 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 235000016623 Fragaria vesca Nutrition 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 229920000926 Galactomannan Polymers 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 244000017020 Ipomoea batatas Species 0.000 description 1
- 235000002678 Ipomoea batatas Nutrition 0.000 description 1
- 241001125831 Istiophoridae Species 0.000 description 1
- 240000007049 Juglans regia Species 0.000 description 1
- 235000009496 Juglans regia Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- GMPKIPWJBDOURN-UHFFFAOYSA-N Methoxyamine Chemical compound CON GMPKIPWJBDOURN-UHFFFAOYSA-N 0.000 description 1
- 240000005561 Musa balbisiana Species 0.000 description 1
- 235000018290 Musa x paradisiaca Nutrition 0.000 description 1
- 241000238413 Octopus Species 0.000 description 1
- 235000014643 Orbignya martiana Nutrition 0.000 description 1
- 244000021150 Orbignya martiana Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000003447 Pistacia vera Nutrition 0.000 description 1
- 240000006711 Pistacia vera Species 0.000 description 1
- 241000269980 Pleuronectidae Species 0.000 description 1
- 241001098054 Pollachius pollachius Species 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 240000007651 Rubus glaucus Species 0.000 description 1
- 235000011034 Rubus glaucus Nutrition 0.000 description 1
- 235000009122 Rubus idaeus Nutrition 0.000 description 1
- 241000269851 Sarda sarda Species 0.000 description 1
- 241000269821 Scombridae Species 0.000 description 1
- 241000238371 Sepiidae Species 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 244000040738 Sesamum orientale Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 241001223864 Sphyraena barracuda Species 0.000 description 1
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 1
- 241001062472 Stokellia anisodon Species 0.000 description 1
- 239000004376 Sucralose Substances 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 235000006468 Thea sinensis Nutrition 0.000 description 1
- 241000276707 Tilapia Species 0.000 description 1
- 240000000851 Vaccinium corymbosum Species 0.000 description 1
- 235000003095 Vaccinium corymbosum Nutrition 0.000 description 1
- 240000001717 Vaccinium macrocarpon Species 0.000 description 1
- 235000012545 Vaccinium macrocarpon Nutrition 0.000 description 1
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 1
- 235000002118 Vaccinium oxycoccus Nutrition 0.000 description 1
- 235000011453 Vigna umbellata Nutrition 0.000 description 1
- 240000001417 Vigna umbellata Species 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 241000482268 Zea mays subsp. mays Species 0.000 description 1
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000000619 acesulfame-K Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 235000020224 almond Nutrition 0.000 description 1
- FYGDTMLNYKFZSV-DZOUCCHMSA-N alpha-D-Glcp-(1->4)-alpha-D-Glcp-(1->4)-D-Glcp Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)O[C@H](O[C@@H]2[C@H](OC(O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-DZOUCCHMSA-N 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- WQZGKKKJIJFFOK-DVKNGEFBSA-N alpha-D-glucose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-DVKNGEFBSA-N 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 235000019513 anchovy Nutrition 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 235000019463 artificial additive Nutrition 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 235000020279 black tea Nutrition 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 235000021014 blueberries Nutrition 0.000 description 1
- 229910021538 borax Inorganic materials 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 235000013736 caramel Nutrition 0.000 description 1
- 230000005189 cardiac health Effects 0.000 description 1
- 230000036996 cardiovascular health Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000008370 chocolate flavor Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 239000008373 coffee flavor Substances 0.000 description 1
- 238000010668 complexation reaction Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 235000004634 cranberry Nutrition 0.000 description 1
- 230000001687 destabilization Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 238000004186 food analysis Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000021255 galacto-oligosaccharides Nutrition 0.000 description 1
- 150000003271 galactooligosaccharides Chemical class 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 230000007407 health benefit Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000000887 hydrating effect Effects 0.000 description 1
- 239000000416 hydrocolloid Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 description 1
- BJHIKXHVCXFQLS-PQLUHFTBSA-N keto-D-tagatose Chemical compound OC[C@@H](O)[C@H](O)[C@H](O)C(=O)CO BJHIKXHVCXFQLS-PQLUHFTBSA-N 0.000 description 1
- 150000002605 large molecules Chemical class 0.000 description 1
- 235000020640 mackerel Nutrition 0.000 description 1
- 125000000311 mannosyl group Chemical group C1([C@@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- AZQWKYJCGOJGHM-UHFFFAOYSA-N para-benzoquinone Natural products O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000037081 physical activity Effects 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 235000020233 pistachio Nutrition 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 230000000291 postprandial effect Effects 0.000 description 1
- 239000001508 potassium citrate Substances 0.000 description 1
- 229960002635 potassium citrate Drugs 0.000 description 1
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 1
- 235000011082 potassium citrates Nutrition 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 229940119224 salmon oil Drugs 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000036186 satiety Effects 0.000 description 1
- 235000019627 satiety Nutrition 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 235000011083 sodium citrates Nutrition 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 235000011008 sodium phosphates Nutrition 0.000 description 1
- 235000010339 sodium tetraborate Nutrition 0.000 description 1
- 239000008279 sol Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000013322 soy milk Nutrition 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 229940013618 stevioside Drugs 0.000 description 1
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 1
- 235000019202 steviosides Nutrition 0.000 description 1
- 235000019408 sucralose Nutrition 0.000 description 1
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- BSVBQGMMJUBVOD-UHFFFAOYSA-N trisodium borate Chemical compound [Na+].[Na+].[Na+].[O-]B([O-])[O-] BSVBQGMMJUBVOD-UHFFFAOYSA-N 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 239000008371 vanilla flavor Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
- 235000005282 vitamin D3 Nutrition 0.000 description 1
- 239000011647 vitamin D3 Substances 0.000 description 1
- 229940021056 vitamin d3 Drugs 0.000 description 1
- 235000020234 walnut Nutrition 0.000 description 1
- 239000010698 whale oil Substances 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/62—Clouding agents; Agents to improve the cloud-stability
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/18—Lipids
- A23V2250/186—Fatty acids
- A23V2250/1866—Conjugated Linoleic acid
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/18—Lipids
- A23V2250/186—Fatty acids
- A23V2250/1868—Docosahexaenoic acid
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/18—Lipids
- A23V2250/186—Fatty acids
- A23V2250/187—Eicosapentaenoic acid
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/18—Lipids
- A23V2250/186—Fatty acids
- A23V2250/1872—Linoleic acid
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/30—Other Organic compounds
- A23V2250/314—Ubiquinone, coenzyme Qn
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/70—Vitamins
- A23V2250/712—Vitamin E
Abstract
Description
본 발명은 오일, 말토덱스트린 및 펙틴을 포함하는 음료 조성물 및 이의 제조방법에 관한 것이다.The present invention relates to a beverage composition comprising oil, maltodextrin and pectin and a method for preparing the same.
식품 분말은 식료품 또는 음료를 제조하는 경제적이면서 신속하고 단순한 방식을 제공하므로 소비자들에게 인기가 높다. 분말은 또한 유체로 수화되고 임의로 기타의 성분과 혼합되고, 추가의 가공으로 처리되어 소비자에게 시판되는 식품 및 음료 제품을 형성하는 중간 성분으로서 제조 공정에 사용된다. Food powders are popular with consumers because they provide an economical, fast and simple way to prepare foodstuffs or beverages. The powder is also hydrated with a fluid, optionally mixed with other ingredients, subjected to further processing and used in manufacturing processes as an intermediate ingredient to form food and beverage products marketed to the consumer.
그러나, 다수의 시판중인 분말은 고온수와 같은 유체와 혼합 시 함께 덩어리를 형성하여 유체에 고르게 분산되지 못하는 경향을 갖고 있다. 예를 들면, 분말을 유체에 첨가 시, 분말은 종종 유체에 분산되기보다는 응집되어 유체의 상부에 부유하거나 또는 덩어리채로 바닥에 가라앉게 된다. However, many commercially available powders tend to form agglomerates together when mixed with a fluid such as hot water, so that they are not evenly dispersed in the fluid. For example, when powder is added to a fluid, the powder often aggregates rather than disperses in the fluid and floats on top of the fluid or settles to the bottom as a lump.
따라서, 유분 친화적인 생리활성 물질을 음료에 첨가하는 경우 분산이 고르게 되지 못해 섭취 시 이질감이 느껴지는 경우가 많은 실정이다.Therefore, when an oil-friendly physiologically active substance is added to a beverage, the dispersion is not even, so a sense of heterogeneity is often felt when ingested.
하지만 수불용성인 생리활성 물질들은 빛, 산소 또는 열과 같은 외부 환경에 취약하며, 수용액 상에서 결정을 형성하여 액상 제품에 적용하기 어려움이 많았다. 또한, 리포좀화 같은 캡슐화 방법을 적용할 경우 건강기능식품 공전 분석법으로 분석 함량을 제대로 계산하지 못한다는 문제점이 있었다. 그리고 결정을 형성하여 석출되기 때문에 여러 유화 기술을 적용하기 어려운 점도 있었다.However, water-insoluble physiologically active substances are vulnerable to external environments such as light, oxygen, or heat, and they form crystals in aqueous solution, making it difficult to apply to liquid products. In addition, when an encapsulation method such as liposome formation is applied, there is a problem that the analysis content cannot be properly calculated by the public health functional food analysis method. Also, it was difficult to apply various emulsification techniques because crystals were formed and precipitated.
음료 제조 공정에서, 상기와 같은 단점은 제조 시스템에 비용 및 복잡성을 부가하여 가공을 지연시키는 문제를 일으킬 수 있다. 이를 해결하기 위해 통상적으로 분산성 및 유동성을 증진시키기 위하여 전분, 유동 보조제 및 기타의 유화제를 사용하여 왔다. 그러나, 기존 식품 음료에서 유용성 성분을 첨가하는 경우, 유화제를 이용한 유화 시스템을 사용하여 안정된 제품을 만들기 위해서는 상기 유용성 성분에 맞춰 유화제의 성분, 점증제, pH 및 살균 시스템 등을 세밀하게 구성해야 하며, 이에 따라 개발 기간이 늘어나고 생산하고자 하는 제형에 따라 필요한 생산설비가 달라지는 문제가 있었다. 그리고 합성 유화제 등의 합성 첨가물의 사용으로 인해 소비자들의 불안감이 증가하고 있으며, 천연 유화제는 합성 유화제에 비해 유화력 및 분산안정성이 떨어져 음료 상품화에 적용되기 어렵다는 단점이 있다. 또한, 캡슐레이션 기술을 통하여 리포좀화 할 경우 리포좀화 된 원료를 수화시켜 가공하는 공정에서 안정성이 떨어지고, 이를 건강기능식품에 적용하는 경우, 건강기능식품 공전 분석법으로 함량 분석 시 검출이 제대로 안되는 문제점이 여전히 존재한다.In the beverage manufacturing process, the above disadvantages may cause a problem of delaying the processing by adding cost and complexity to the manufacturing system. In order to solve this problem, starch, flow aids and other emulsifiers have been used to improve dispersibility and fluidity. However, in the case of adding oil-soluble components in existing food and beverages, in order to make a stable product using an emulsifying system using an emulsifier, the components of the emulsifier, thickener, pH, and sterilization system must be configured in detail according to the oil-soluble component, Accordingly, there was a problem in that the development period was extended and the required production equipment was different depending on the formulation to be produced. And the use of synthetic additives such as synthetic emulsifiers is increasing consumers' anxiety, and natural emulsifiers have poor emulsification power and dispersion stability compared to synthetic emulsifiers, making them difficult to apply to beverage commercialization. In addition, when liposomes are formed through encapsulation technology, stability is lowered in the process of hydrating and processing liposomed raw materials. It still exists.
이에, 본 발명자들은 이러한 문제를 해결하기 위해 유화제의 사용 없이도 수불용성 물질을 분산시킬 수 있으며, 이를 통해 외부 환경에 의해 쉽게 분해되지 않는 제형을 개발하였다. 상기 제형에 생리활성 물질이 담지 되어도 건강기능식품 분석이 가능하고, 유효성분의 손실이 적으며, 섭취에 불편함이 없는 안정한 제형을 개발하여 발명을 완성하였다. Accordingly, the present inventors have developed a formulation that can disperse the water-insoluble material without the use of an emulsifier to solve this problem, and is not easily decomposed by the external environment through this. The invention was completed by developing a stable formulation that enables analysis of health functional foods even when physiologically active substances are supported in the formulation, has little loss of active ingredients, and has no inconvenience in ingestion.
일 양상은 오일, 말토덱스트린(maltodextrin) 및 펙틴(pectin)을 포함하는, 오일 수분산 음료 조성물을 제공하는 것이다.One aspect is to provide an oil-dispersed beverage composition comprising oil, maltodextrin and pectin.
다른 양상은 (1) 오일을 말토덱스트린에 분산시켜 오일 및 말토덱스트린 복합체를 제조하는 단계, (2) 펙틴 수용액을 준비하는 단계, 및 (3) 상기 오일 및 말토덱스트린 복합체를 펙틴 수용액에 분산하여 펙틴 보호 콜로이드를 형성하는 단계를 포함하는 오일 수분산 음료 조성물의 제조방법을 제공하는 것이다.Another aspect is (1) dispersing the oil in maltodextrin to prepare an oil and maltodextrin complex, (2) preparing an aqueous pectin solution, and (3) dispersing the oil and maltodextrin complex in an aqueous pectin solution to pectin It is to provide a method for preparing an oil-water dispersion beverage composition comprising the step of forming a protective colloid.
일 양상은 오일, 말토덱스트린 및 펙틴을 포함하는, 오일 수분산 음료 조성물을 제공하는 것이다.One aspect is to provide an oil-dispersed beverage composition comprising oil, maltodextrin and pectin.
일 구체예에 따르면 상기 오일 수분산 음료 조성물은 생리활성 물질을 더 포함할 수 있다.According to one embodiment, the oil-dispersed beverage composition may further include a physiologically active material.
본 명세서에서 용어 "생리활성 물질"은 생물의 대사작용을 촉진 또는 억제시키는 화합물을 의미한다. 이러한 생리활성 물질은 면역력을 증강시켜주고, 혈액 속의 콜레스테롤을 떨어뜨려 심장 질환을 예방하기도 하는 등 다양한 질병의 치료 또는 예방 효과를 발휘한다. 생리활성 물질로는, 예를 들어, 펩티드, 단백질, DNA 및 RNA 등의 핵산, 당, 당단백, 또는 그 밖의 고분자 혹은 저분자 화합물이 있다.As used herein, the term "bioactive substance" refers to a compound that promotes or inhibits the metabolism of an organism. These physiologically active substances enhance immunity, reduce cholesterol in the blood, and prevent heart disease, and have therapeutic or preventive effects on various diseases. Examples of the physiologically active substance include nucleic acids such as peptides, proteins, DNA and RNA, sugars, glycoproteins, and other high molecular weight or low molecular weight compounds.
상기 생리활성 물질은 코엔자임Q10, 레티놀(retinol), 토코페롤(tocopherol), 아스타잔틴(astaxanthin), 루테인(lutein), 오메가3, 감마-리놀렌산(γ-linolenic acid), 옥타코사놀(octacosanol), 알콕시글리세롤(alkylglycerol), 공액리놀렌산(conjugated linoleic acid)) 및 파이토케미칼(phytochemical)로 이루어진 군으로부터 선택되는 하나 이상인 것일 수 있으나, 이에 제한되지 않는다.The physiologically active substance is coenzyme Q10, retinol, tocopherol, astaxanthin, lutein, omega 3, gamma-linolenic acid, octacosanol, alkoxyglycerol. (alkylglycerol), conjugated linoleic acid (conjugated linoleic acid), and may be at least one selected from the group consisting of phytochemicals, but is not limited thereto.
본 명세서에서 용어 "코엔자임Q10(CoQ10, 코큐텐)"은 우리 몸에 필요한 에너지를 만드는 데 사용되는 보효소(coenzyme)로, 우리 몸에서 에너지 대사가 가장 활발히 이뤄지는 각 세포 내의 미토콘드리아에서 전자전달계에 관여해 ATP생성에 깊은 관계가 있는 물질을 의미한다. 상기 코엔자임Q10은 황색 또는 오렌지색의, 냄새나 맛이 없는 비타민과 유사한 특성을 가진 지용성 퀴논(quinone) 화합물로 유분에 잘 녹는 생리활성 물질이다. 또한, 상기 코엔자임Q10은 세포 내 미토콘드리아 안에서 에너지를 생성하는데 중요한 기능을 하며, 세포 에너지의 95%를 차지한다. 또한 코엔자임Q10은 음식물의 분해 및 소화를 도와, 미토콘드리아가 섭취한 음식으로부터 지방과 당분을 받아 세포 에너지로 변환시키는 것을 돕는다. 이를 통해 신진대사의 흐름을 원활하게 하며, 심혈관개선 및 심장 건강과 근육 그리고 조직의 피로회복에 도움을 준다. 이러한 코엔자임Q10은 항산화, 높은 혈압 감소에 도움을 줄 수 있는 건강기능식품 기능성 원료로 사용되고 있으며, 코엔자임Q10이 부족하면 에너지 생성이 원활하지 못해 신체 활력이 저하되는 현상 발생하게 된다. 또한, 코엔자임Q10은 수용액에서 용해도가 낮아 경구 섭취 시 생체 이용률이 낮고, 빛, 산소에 민감하며, 낮은 pH에서, 예를 들면 pH 1 내지 2에서 불안정화 되는 단점을 지니고 있다.As used herein, the term "coenzyme Q10 (CoQ10, CoQ10)" is a coenzyme used to make energy necessary for our body. Substances that are closely related to creation. The coenzyme Q10 is a fat-soluble quinone compound having a yellow or orange color, odor or taste, and similar properties to vitamins, and is a physiologically active substance soluble in oil. In addition, the coenzyme Q10 plays an important function in generating energy in the mitochondria in the cell, and occupies 95% of the cell energy. In addition, coenzyme Q10 helps the decomposition and digestion of food, helping the mitochondria take fat and sugar from the food and convert it into cellular energy. This facilitates the flow of metabolism and helps improve cardiovascular health, heart health, and recovery from muscle and tissue fatigue. Coenzyme Q10 is used as a functional raw material for health functional food that can help antioxidants and reduce high blood pressure. If coenzyme Q10 is insufficient, energy production is not smooth and the body's vitality is lowered. In addition, coenzyme Q10 has low solubility in aqueous solution, low bioavailability upon oral ingestion, sensitivity to light and oxygen, and destabilization at low pH, for example, pH 1-2.
상기 오일은 식용 오일일 수 있다.The oil may be an edible oil.
본 명세서에서 용어 "식용 오일"은 독성이 없고 소비 가능한 오일을 의미한다. 식용 오일은 바람직하게는 건강상 이익을 제공할 수 있다. 식용 오일은 전형적으로 대기압에서 0℃ 내지 25℃의 온도 범위 내에서 액체인 트리글리세리드 조성물이다. 상기 오일은 일반적으로 소수성이며, 식물성 오일 또는 동물성 오일과 같은 천연 공급원으로부터 수득 될 수 있다. As used herein, the term “edible oil” means non-toxic and consumable oil. Edible oils may preferably provide health benefits. Edible oils are triglyceride compositions that are typically liquid within a temperature range of 0° C. to 25° C. at atmospheric pressure. The oils are generally hydrophobic and may be obtained from natural sources such as vegetable or animal oils.
일 구체예에 따르면, 상기 식물성 오일은 아르간 오일, 아마란스 오일, 살구씨 오일, 아티초크 오일, 바바수야자유, 보르네오 수지 넛(borneo tallow nut) 오일, 조롱박유, 버팔로 조롱박 오일, 보리지 오일, 아마씨유, 카롭 열매 오일, 양귀비 씨 오일, 벤(ben) 오일 참깨 오일, 버섯 오일, 헤이즐넛 오일, 홍화유, 해바라기유, 카놀라유, 땅콩유, 대두유, 쌀겨 오일, 유채 오일, 팜 커넬 오일, 면실유, 잇꽃유, 옥수수유, 팜유, 올리브유, 코코넛유, 코코아유, 달맞이꽃 오일, 팜 커널유, 아몬드유, 호호바유, 아보카도유, 호두 오일 및 캐스터 오일로 이루어진 군으로부터 선택되는 하나 이상인 것일 수 있으나, 이에 제한되지 않는다.According to one embodiment, the vegetable oil is argan oil, amaranth oil, apricot seed oil, artichoke oil, babassu palm oil, borneo tallow nut oil, gourd oil, buffalo gourd oil, borage oil, flaxseed oil Oil, carob oil, poppy seed oil, ben oil, sesame oil, mushroom oil, hazelnut oil, safflower oil, sunflower oil, canola oil, peanut oil, soybean oil, rice bran oil, rapeseed oil, palm kernel oil, cottonseed oil, safflower oil , corn oil, palm oil, olive oil, coconut oil, cocoa oil, evening primrose oil, palm kernel oil, almond oil, jojoba oil, avocado oil, may be at least one selected from the group consisting of walnut oil and castor oil, but is not limited thereto. does not
상기 동물성 오일은 크릴오일, 스쿠알렌, 스쿠알란, 난황오일, 밍크오일, 우지, 돈지, 양지, 계유, 번데기오일 및 생선오일로 이루어진 군으로부터 선택되는 하나 이상인 것일 수 있으나, 이에 제한되지 않는다.The animal oil may be at least one selected from the group consisting of krill oil, squalene, squalane, egg yolk oil, mink oil, beef tallow, lard, brisket, chicken oil, pupa oil and fish oil, but is not limited thereto.
상기 생선오일은 폴락 오일(pollack oil), 가다랭이 오일, 정어리(pilchard) 오일, 틸라피아 오일, 참치 오일, 농어 오일, 넙치 오일, 청새치 오일, 창꼬치 오일, 대구 오일, 청어 오일, 정어리(sardine) 오일, 오징어 오일, 갑오징어 오일, 문어 오일, 고래 오일, 멸치 오일, 빙어 오일, 청어 오일, 고등어 오일, 연어 오일, 참치 오일 및 상어 오일로 이루어진 군으로부터 선택되는 하나 이상인 것일 수 있다.The fish oil is pollack oil, bonito oil, sardine oil, tilapia oil, tuna oil, sea bass oil, halibut oil, marlin oil, barracuda oil, cod oil, herring oil, sardine oil, It may be at least one selected from the group consisting of squid oil, cuttlefish oil, octopus oil, whale oil, anchovy oil, smelt oil, herring oil, mackerel oil, salmon oil, tuna oil and shark oil.
본 명세서에서 용어 "말토덱스트린"은 주로 글리코 시드 (1 → 4) 결합에 의해 결합된 α-D-글루코스의 가수분해된 전분 단위이다. 전분의 가수분해 생성물로서, 말토덱스트린은 당류, 주로 D-글루코오스, 말토즈 및 일련의 올리고당 및 다당류의 혼합물로 이루어질 수 있다. As used herein, the term "maltodextrin" is a hydrolyzed starch unit of α-D-glucose, which is mainly bound by glycosidic (1 → 4) bonds. As a hydrolysis product of starch, maltodextrin can consist of sugars, mainly D-glucose, maltose and a series of mixtures of oligosaccharides and polysaccharides.
상기 말토덱스트린은 타피오카 말토덱스트린(tapioca maltodextrin), 마치종 옥수수 말토덱스트린(dent corn maltodextrin), 왁스성 옥수수 말토덱스트린 및 감자 말토덱스트린으로 이루어진 군으로부터 선택되는 하나 이상인 것일 수 있다. The maltodextrin may be at least one selected from the group consisting of tapioca maltodextrin, dent corn maltodextrin, waxy corn maltodextrin, and potato maltodextrin.
상기 말토덱스트린은 수불용성 말토덱스트린일 수 있다. 본 명세서에서 용어 “수불용성”은 물에 거의 녹지 않거나, 매우 소량으로 녹는 성질을 의미한다. 따라서 상기 수불용성 말토덱스트린은 유효성분을 외부 수상부계와 차단하는 효과가 있는 말토덱스트린을 의미하고, 상기 수불용성 말토덱스트린은 수불용성의 특성을 갖는 모든 말토덱스트린을 포함한다. 상기 말토덱스트린은 물에 혼합 시 침전하게 되는 성질이 있으며, 오일을 캡슐레이션 한 경우, 말토덱스트린 내의 메트릭스 부분에 오일들이 흡착되어 포접하게 된다. 따라서 수불용성 말토덱스트린에 오일을 캡슐레이션 한 경우, 오일을 분출하지 않고 포접한 상태로 침전하게 된다.The maltodextrin may be water-insoluble maltodextrin. As used herein, the term “water-insoluble” refers to a property of being hardly soluble in water or soluble in a very small amount. Accordingly, the water-insoluble maltodextrin refers to maltodextrin having an effect of blocking the active ingredient from the external aqueous phase system, and the water-insoluble maltodextrin includes all maltodextrins having water-insoluble properties. The maltodextrin has a property of being precipitated when mixed with water, and when the oil is encapsulated, the oils are adsorbed and encapsulated in the matrix part in the maltodextrin. Therefore, when oil is encapsulated in water-insoluble maltodextrin, the oil is precipitated in an encapsulated state without ejection.
상기 수불용성 말토덱스트린은 글루코오스 당량(dextrose equivalent: DE)이 0.01 내지 20일 수 있다. 또한, 상기 수불용성 말토덱스트린 내에 흡착가능한 오일은 수불용성 말토덱스트린 중량 대비 0.01 내지 60 중량%일 수 있다.The water-insoluble maltodextrin may have a glucose equivalent (DE) of 0.01 to 20. In addition, the oil adsorbable in the water-insoluble maltodextrin may be 0.01 to 60% by weight based on the weight of the water-insoluble maltodextrin.
일 구체예에 따르면, 상기 수불용성 말토덱스트린은 타피오카 말토덱스트린일 수 있다.According to one embodiment, the water-insoluble maltodextrin may be tapioca maltodextrin.
본 명세서에서 용어 "펙틴"은 약 300 내지 1,000개의 모노사카라이드(monosaccharide) 단위를 함유하는 폴리사카라이드(polysaccharide)를 의미한다. 펙틴은 야채 및 과일 식물과 같은 대부분의 식물의 세포벽에서 발견되며, 펙틴의 주요한 모노사카라이드 단위는 D-갈락투론산(galacturonic acid) 그룹이다. 전형적으로, 펙틴의 분자량은 약 50,000 내지 150,000 달톤이고, 폴리사카라이드의 D-갈락투론산 그룹은 메틸 그룹으로 에스테르화될 수 있다. 그리고 펙틴은 D-갈락투론산 그룹의 에스테르화의 정도를 나타내는 에스테르화도(degree of esterification: DE)에 의해 분류될 수 있다. 상기 DE는 전체 갈락투론산 중 에스테르화된 갈락투론산 카르복실기의 비율을 나타내는 수치 (%)이며, 고 메톡실(high methoxyl: HM) 펙틴은 50% 이상의 DE를 갖는 반면, 저 메톡실(low methoxyl: LM) 펙틴은 50% 미만의 DE를 갖는다. 상기 펙틴은 고 메톡실 에스테르화 펙틴(high methoxyl esterified pectin), 저 메톡실 에스테르화 펙틴(low methoxyl esterified pectin) 또는 저 메톡실 아미드 펙틴(low methoxyl amide pectin)일 수 있다.As used herein, the term “pectin” refers to a polysaccharide containing about 300 to 1,000 monosaccharide units. Pectin is found in the cell wall of most plants, such as vegetables and fruit plants, and the main monosaccharide unit of pectin is the D-galacturonic acid group. Typically, the molecular weight of pectin is about 50,000 to 150,000 daltons, and the D-galacturonic acid group of the polysaccharide can be esterified with a methyl group. And pectin can be classified by the degree of esterification (DE) indicating the degree of esterification of the D-galacturonic acid group. The DE is a numerical value (%) indicating the ratio of esterified galacturonic acid carboxyl groups in the total galacturonic acid, and high methoxyl (HM) pectin has a DE of 50% or more, while low methoxyl : LM) pectin has a DE of less than 50%. The pectin may be high methoxyl esterified pectin, low methoxyl esterified pectin, or low methoxyl amide pectin.
일 구체예에 따르면, 상기 음료 조성물은 증점제를 추가로 더 포함하는 것일 수 있다.According to one embodiment, the beverage composition may further include a thickener.
상기 증점제는 한천, 산탄검, 로커스트빈검, 젤라틴, 카라기난, 구아검, 젤란검, 알긴산, 펙틴, 아라비아검, 카르복시 메틸셀룰로오스, 메틸셀룰로오스, 헤미 셀룰로오스 및 셀룰로오스로 이루어진 군으로부터 선택된 하나 이상일 수 있으나, 이에 제한되지 않는다.The thickener may be at least one selected from the group consisting of agar, xanthan gum, locust bean gum, gelatin, carrageenan, guar gum, gellan gum, alginic acid, pectin, gum arabic, carboxymethylcellulose, methylcellulose, hemicellulose and cellulose, but this not limited
상기 로커스트빈검은 고분자량 하이드로콜로이드 다당류로서, 주로 갈락토만난(galactomannan)으로 화학적으로 기술될 수 있는 글리코시드 결합을 통해 결합된 갈락토오스 및 만노즈(mannose) 단위로 구성된다. 이는 고온 또는 저온의 물에 분산되어 소량의 소듐 보레이트의 첨가에 의해 겔로 전환될 수 있는, pH 5.4 내지 7.0를 갖는 졸을 형성한다.The locust bean gum is a high molecular weight hydrocolloid polysaccharide, mainly composed of galactose and mannose units linked through glycosidic bonds, which can be chemically described as galactomannan. It is dispersed in hot or cold water to form a sol having a pH of 5.4 to 7.0, which can be converted to a gel by the addition of a small amount of sodium borate.
상기 셀룰로오스는 펙틴과 함께 식물의 세포벽을 구성하는 성분으로 펙틴의 분산 안정도를 향상시켜주며, 불용성 식이섬유로서 배변 개선, 식후 혈당 상승 억제 및 포만감 제공 등의 효능이 있으며 빛에 의한 유효성분의 분해를 억제할 수 있어 현탁제로도 사용할 수 있다.The cellulose is a component constituting the cell wall of plants together with pectin, and improves the dispersion stability of pectin, and as an insoluble dietary fiber, it has effects such as improving bowel movements, suppressing postprandial blood sugar rise and providing a feeling of satiety, and decomposition of active ingredients by light It can be used as a suspending agent.
상기 생리활성 물질의 함량은 조성물 총 중량 대비 0.01 내지 10 중량%, 예를 들면, 0.01 내지 9 중량%, 0.01 내지 7 중량%, 0.05 내지 7 중량%, 0.05 내지 5 중량%, 0.1 내지 5 중량% 또는 0.1 내지 3 중량%일 수 있다. The content of the bioactive material is 0.01 to 10% by weight, for example, 0.01 to 9% by weight, 0.01 to 7% by weight, 0.05 to 7% by weight, 0.05 to 5% by weight, 0.1 to 5% by weight relative to the total weight of the composition or 0.1 to 3% by weight.
상기 오일의 함량은 조성물 총 중량 대비 0.01 내지 15 중량%, 예를 들면, 0.1 내지 10 중량 %, 0.05 내지 10 중량%, 0.06 내지 10 중량%, 0.08 내지 10 중량%, 0.09 내지 10 중량%, 0.1 내지 10 중량%, 0.1 내지 9 중량%, 0.1 내지 8 중량%, 0.1 내지 7 중량% 또는 0.1 내지 5 중량%일 수 있다. The content of the oil is 0.01 to 15% by weight relative to the total weight of the composition, for example, 0.1 to 10% by weight, 0.05 to 10% by weight, 0.06 to 10% by weight, 0.08 to 10% by weight, 0.09 to 10% by weight, 0.1 to 10% by weight, 0.1 to 9% by weight, 0.1 to 8% by weight, 0.1 to 7% by weight or 0.1 to 5% by weight.
상기 오일 및/또는 생리활성 물질의 함량이 상기 중량%를 초과할 경우(예를 들어, 생리활성 물질이 10중량% 초과한 경우, 오일이 15중량% 초과한 경우) 말토덱스트린 복합체를 형성할 때 고형분의 함량이 많아져 액상 제품에 적용하기 부적절해진다.When the content of the oil and/or bioactive substance exceeds the above wt% (for example, when the bioactive substance exceeds 10 wt%, when the oil exceeds 15 wt%) maltodextrin complex is formed The high solid content makes it unsuitable for application to liquid products.
또한, 상기 말토덱스트린의 함량은 조성물 총 중량 대비 0.05 내지 20 중량%, 예를 들면, 0.05 내지 18 중량%, 0.06 내지 16 중량%, 0.07 내지 14 중량%, 0.08 내지 12 중량%, 0.09 내지 10 중량% 또는 0.1 내지 10 중량%일 수 있다.In addition, the content of the maltodextrin is 0.05 to 20% by weight, for example, 0.05 to 18% by weight, 0.06 to 16% by weight, 0.07 to 14% by weight, 0.08 to 12% by weight, 0.09 to 10% by weight relative to the total weight of the composition % or 0.1 to 10% by weight.
상기 펙틴의 함량은 조성물 총 중량 대비 0.3 내지 10 중량%, 예를 들면, 0.3 내지 9 중량%, 0.3 내지 8 중량%, 0.3 내지 7 중량%, 0.3 내지 6 중량%, 0.4 내지 5 중량%, 0.4 내지 4 중량%, 0.5 내지 4 중량% 또는 0.5 내지 3 중량%일 수 있다.The content of the pectin is 0.3 to 10% by weight relative to the total weight of the composition, for example, 0.3 to 9% by weight, 0.3 to 8% by weight, 0.3 to 7% by weight, 0.3 to 6% by weight, 0.4 to 5% by weight, 0.4 to 4% by weight, 0.5 to 4% by weight or 0.5 to 3% by weight.
일 구체예에 따르면, 상기 수분산 음료 조성물은 상기 말토덱스트린 및 오일을 1.5 내지 15 : 1, 예를 들면, 1.5 내지 14 : 1, 1.5 내지 13 : 1, 1.5 내지 12 : 1, 1.5 내지 11 : 1 또는 1.5 내지 10 : 1 의 중량비로 포함하는 것일 수 있다. 상기 최대 적용 가능한 말토덱스트린 및 오일의 비율은 1.5 : 1일 수 있다.According to one embodiment, the aqueous dispersion beverage composition contains the maltodextrin and oil from 1.5 to 15: 1, for example, from 1.5 to 14: 1, from 1.5 to 13: 1, from 1.5 to 12: 1, from 1.5 to 11: It may be included in a weight ratio of 1 or 1.5 to 10: 1. The maximum applicable ratio of maltodextrin and oil may be 1.5:1.
상기 오일 수분산 음료 조성물은 농축액, 감미제, 산도 조절제, 착향제, 조직개량제, 보존제, 안정제, 영양 강화제 및 향료로 이루어진 군으로부터 선택되는 어느 하나 이상을 추가로 더 포함할 수 있으나, 이에 제한되지 않는다.The oil-water dispersion beverage composition may further include any one or more selected from the group consisting of a concentrate, a sweetener, an acidity regulator, a flavoring agent, a tissue improver, a preservative, a stabilizer, a nutritional enhancer, and a flavoring agent, but is not limited thereto. .
상기 산도 조절제는 구연산 또는 인산일 수 있으나, 이에 제한되지 않는다.The acidity control agent may be citric acid or phosphoric acid, but is not limited thereto.
상기 구연산은 제품의 산도와 pH를 조절하여 산미를 증진시키거나 미생물에 대한 발육 억제 역할을 할 수 있으며, 인산은 산미에 미치는 영향을 최소화하여 억제하고 반면에 pH를 원하는 수준만큼 낮추는 역할을 할 수 있다. 따라서, pH 를 3 내지 5, 예를 들면, 3.5 내지 4.5로 조절할 수 있다. pH가 5를 넘어가면 균이 자라기 적합한 환경이 되어 제품의 유통기한이 단축된다는 문제가 있으며, pH가 3 이하로 내려갈 경우 펙틴의 등전점(isoelectric point)을 넘어 알짜 전하(net charge)가 양의 값이 되어 보호 콜로이드로서 작용하기 어려운 문제가 있다.The citric acid can improve acidity by adjusting the acidity and pH of the product or play a role in inhibiting the growth of microorganisms, and phosphoric acid can play a role in suppressing by minimizing the effect on acidity, while lowering the pH to a desired level. have. Accordingly, the pH may be adjusted to 3-5, for example, 3.5 to 4.5. When the pH exceeds 5, there is a problem that the shelf life of the product is shortened as the environment is suitable for bacteria to grow. Therefore, there is a problem that it is difficult to act as a protective colloid.
또한, pH 조정을 위해 상기 산과 이들의 짝염을 버퍼로 이용하여 산도를 추가적으로 조절할 수 있다. 구체적으로 구연산나트륨, 구연산칼륨, 인산나트륨, 인산칼륨 또는 이들의 혼합물 등을 이용할 수 있다. 상기 버퍼는 최종 제품 및 그의 희석 형태에서의 풍미 개선 효과적일 수 있다. In addition, for pH adjustment, acidity may be additionally adjusted by using the acid and its conjugate salt as a buffer. Specifically, sodium citrate, potassium citrate, sodium phosphate, potassium phosphate, or a mixture thereof may be used. The buffer may be effective in improving flavor in the final product and its diluted form.
상기 감미제는 음료의 감미질을 개선하기 위해, 설탕, 설탕 대체 감미제, 고감미료, 올리고당으로 이루어진 군에서 선택된 하나 이상일 수 있으나, 이에 제한되지 않는다. 상기 설탕은 종류에 특별한 제한이 없으며, 예를 들면, 백설탕, 흑설탕, 황설탕 또는 당 흡수율을 낮추거나 칼로리를 낮춘 기능성 설탕일 수 있다. The sweetener may be one or more selected from the group consisting of sugar, sugar substitute sweetener, high sweetener, and oligosaccharide in order to improve the sweetness of the beverage, but is not limited thereto. The type of sugar is not particularly limited, and may be, for example, white sugar, brown sugar, brown sugar, or functional sugar that lowers sugar absorption or lowers calories.
상기 설탕 대체 감미제는 과당, 타가토오스, 사이코오스, 포도당, 자일로오즈 및 만노오즈로 이루어진 군에서 선택된 하나 이상일 수 있으나, 이에 제한되는 것은 아니다.The sugar substitute sweetener may be one or more selected from the group consisting of fructose, tagatose, psychoose, glucose, xylose and mannose, but is not limited thereto.
상기 고감미료는 천연감미료 또는 합성감미료일 수 있고, 천연감미료는 스테비오사이드 또는 레바디오사이드일 수 있으며, 합성 감미료로는 수크랄로스, 아세설팜K, 아스파탐 또는 솔비톨일 수 있다. 상기 고감미료를 사용하여 성취되는 단맛의 정도에 따라서 설탕 사용량의 일부를 덱스트린으로 대체할 수도 있다.The high sweetener may be a natural sweetener or a synthetic sweetener, the natural sweetener may be stevioside or revadioside, and the synthetic sweetener may be sucralose, acesulfame K, aspartame or sorbitol. Depending on the degree of sweetness achieved by using the high sweetener, a portion of the amount of sugar used may be substituted with dextrin.
상기 올리고당은 프락토 올리고당, 갈락토 올리고당, 이소말토올리고당 또는 말토 올리고당의 통상의 올리고당일 수 있으나 이에 제한되지 않는다. The oligosaccharide may be a conventional oligosaccharide of fructooligosaccharide, galactooligosaccharide, isomaltooligosaccharide or maltooligosaccharide, but is not limited thereto.
상기 영양 강화제는 니코틴산아미드, 비타민B1염산염, 비타민B2, 비타민B6염산염, 비타민C, 비타민D3, 아미노산, 판토텐산칼슘일 수 있으나, 이에 제한되지 않는다.The nutritional enhancer may be nicotinic acid amide, vitamin B1 hydrochloride, vitamin B2, vitamin B6 hydrochloride, vitamin C, vitamin D3, amino acid, or calcium pantothenate, but is not limited thereto.
상기 향료는 식용 가능한 향료이면 특별한 제한은 없으며, 예를 들어, 드링크향, 딸기향, 바닐라향, 초코향, 녹차향, 사과향, 포도향, 블루베리향, 라즈베리향, 크랜베리향, 수박향, 오렌지향, 바나나향, 카라멜향, 피스타치오향, 밀크향, 요거트향, 레몬향, 밤향, 땅콩향, 커피향, 홍차향, 메론향, 곡물향, 고구마향, 배향, 팥향, 호두향, 아몬드향, 복숭아향, 누룽지향, 로스팅향, 참깨향, 볶은콩향, 시리얼향, 밀크향, 옥수수향일 수 있다.The flavor is not particularly limited as long as it is an edible flavor, for example, drink flavor, strawberry flavor, vanilla flavor, chocolate flavor, green tea flavor, apple flavor, grape flavor, blueberry flavor, raspberry flavor, cranberry flavor, watermelon flavor, orange Fragrance, banana flavor, caramel flavor, pistachio flavor, milk flavor, yogurt flavor, lemon flavor, chestnut flavor, peanut flavor, coffee flavor, black tea flavor, melon flavor, grain flavor, sweet potato flavor, orientation, red bean flavor, walnut flavor, almond flavor, It may be peach flavor, nurungji flavor, roasting flavor, sesame flavor, roasted bean flavor, cereal flavor, milk flavor, corn flavor.
상기 오일 수분산 음료 조성물 내 액상 매질로는 물, 우유 또는 두유 등을 사용할 수 있으며, 이에 한정되는 것은 아니다. As the liquid medium in the oil dispersion beverage composition, water, milk or soy milk may be used, but the present invention is not limited thereto.
상기 오일 수분산 음료 조성물은 유화제를 포함하지 않는 것일 수 있다.The oil-dispersed beverage composition may not include an emulsifier.
본 명세서에서 "용어 "유화제"는 일반적으로 물에 혼합되지 않는 물질을 물에 균일하게 분산시키는 작용을 갖는 것을 의미하며, 계면활성제를 포함한다.As used herein, the term “emulsifier” refers to having an action of uniformly dispersing in water a substance that is not generally mixed with water, and includes a surfactant.
본 명세서에서 "실질적으로 포함하지 않다(substantially does not comprise)" 또는 "포함하지 않다(does not comprise)"는 유화제가 조성물 또는 제형의 물성, 활성, 또는 약리적 활성에 영향을 미치지 않을 정도로 포함되거나 전혀 포함되지 않는 것을 의미한다. 예를 들면, 유화제가 오일 수분산 음료 조성물 대비 0.02 중량% 이하, 0.01 중량% 이하 또는 0.005 중량% 이하로 포함되는 것이나, 전혀 포함되지 않는 것을 포함할 수 있다.As used herein, "substantially does not comprise" or "does not comprise" means that the emulsifier is included or does not affect the physical properties, activity, or pharmacological activity of the composition or formulation at all. means not included. For example, the emulsifier may be included in an amount of 0.02% by weight or less, 0.01% by weight or less, or 0.005% by weight or less, or not included at all compared to the oil-water dispersion beverage composition.
상기 오일 수분산 음료 조성물은 스틱, 바이알, 페트병, 사각 파우치 또는 스탠딩 파우치와 같은 다양한 패키지에 충진하여 살균 공정을 진행할 수 있다.The oil-dispersed beverage composition may be filled in various packages such as sticks, vials, plastic bottles, square pouches or standing pouches to proceed with the sterilization process.
상기 살균은 레토르트 살균, 초고온처리(Ultra-high temperature processing: UHT), 고온순간살균기(High-Temperature Short Time: HTST) 또는 고온 가열 교반을 이용하여 수행할 수 있으나, 이에 제한되지 않는다.The sterilization may be performed using retort sterilization, ultra-high temperature processing (UHT), High-Temperature Short Time (HTST), or high-temperature heating and stirring, but is not limited thereto.
상기 레토르트 살균은 105 내지 121℃에서 15 내지 40분, 예를 들면 20 내지 30분 동안 수행될 수 있다. 상기 UHT는 130 내지 150℃에서 1 내지 5초 동안 수행될 수 있다. 상기 HTST는 70 내지 90℃, 예를 들면 80 내지 85℃에서, 15초 내지 8분동안, 예를 들면 4 내지 5분동안 수행될 수 있다.The retort sterilization may be performed at 105 to 121° C. for 15 to 40 minutes, for example, 20 to 30 minutes. The UHT may be performed at 130 to 150° C. for 1 to 5 seconds. The HTST may be performed at 70 to 90° C., for example, 80 to 85° C., for 15 seconds to 8 minutes, for example, 4 to 5 minutes.
다른 양상은 (1) 오일을 말토덱스트린에 분산시켜 오일 및 말토덱스트린 복합체를 제조하는 단계, (2) 펙틴 수용액을 준비하는 단계, 및 (3) 상기 오일 및 말토덱스트린 복합체를 펙틴 수용액에 분산하여 펙틴 보호 콜로이드를 형성하는 단계를 포함하는 오일 수분산 음료 조성물의 제조방법을 제공하는 것이다.Another aspect is (1) dispersing the oil in maltodextrin to prepare an oil and maltodextrin complex, (2) preparing an aqueous pectin solution, and (3) dispersing the oil and maltodextrin complex in an aqueous pectin solution to pectin It is to provide a method for preparing an oil-water dispersion beverage composition comprising the step of forming a protective colloid.
상기 오일, 말토덱스트린, 펙틴은 상기한 바와 같다.The oil, maltodextrin, and pectin are the same as described above.
상기 단계 (1)의 오일은 생리활성 물질이 담지 된 오일일 수 있다. The oil of step (1) may be an oil in which a physiologically active substance is supported.
상기 생리활성 물질은 상기한 바와 같다.The physiologically active substance is as described above.
일 구체예에 따르면, 상기 생리활성 물질이 담지된 오일을 제조하는 것은 1 내지 35℃, 예를 들면, 10 내지 25℃, 15 내지 25℃ 또는 상온에서 생리활성 물질을 오일에 용해시키면서 수행될 수 있다. 상기 상온 조건은 평상의 온도로서, 15 내지 30℃ 예를 들면, 20 내지 28℃ 또는 24 내지 27℃일 수 있다According to one embodiment, preparing the oil in which the physiologically active material is supported may be performed while dissolving the physiologically active material in the oil at 1 to 35°C, for example, 10 to 25°C, 15 to 25°C or room temperature. have. The room temperature condition is a normal temperature, and may be 15 to 30 ℃, for example, 20 to 28 ℃ or 24 to 27 ℃.
일 구체예에 따르면, 상기 단계 (1)은 분말을 혼합할 수 있는 설비, 예를 들면 푸드프로세서 또는 믹서기로 오일 및 말토덱스트린 복합체를 제조하는 것일 수 있다. According to one embodiment, the step (1) may be to prepare the oil and maltodextrin complex with equipment capable of mixing the powder, for example, a food processor or a blender.
구체적으로, 40% 이하의 습도에서, 예를 들면, 25% 이하의 습도에서, 말토덱스트린을 푸드프로세서에 투입하여 교반시키면서 오일을 투입하여 혼합시키는 것일 수 있다. 상기 혼합은 5분 내지 1시간동안 수행할 수 있지만, 혼합하는 양과 혼합 방법에 따라 적절히 변경될 수 있다. Specifically, at a humidity of 40% or less, for example, at a humidity of 25% or less, maltodextrin may be added to a food processor and mixed with oil while stirring. The mixing may be performed for 5 minutes to 1 hour, but may be appropriately changed depending on the mixing amount and mixing method.
일 구체예에 따르면, 상기 단계 (2)의 펙틴 수용액은 정제수를 70 내지 85℃, 예를 들면 75 내지 80℃로 가온 교반하면서 펙틴을 첨가하여 용해시켜 제조하는 것일 수 있다. According to one embodiment, the aqueous pectin solution of step (2) may be prepared by dissolving purified water by adding pectin while heating and stirring to 70 to 85 ℃, for example, 75 to 80 ℃.
일 구체예에 따르면, 상기 단계 (2)의 상기 펙틴 수용액은 산도 조절제, 예를 들면, 구연산을 첨가하여 pH를 3 내지 5로 조절된 것일 수 있다. According to one embodiment, the aqueous pectin solution in step (2) may be one whose pH is adjusted to 3 to 5 by adding an acidity control agent, for example, citric acid.
상기 단계 (3)은 펙틴 수용액의 온도를 45 내지 55℃, 예를 들면, 46 내지 54℃, 46 내지 53℃, 47 내지 53℃, 47 내지 52℃ 또는 48 내지 52℃로 낮춘 뒤 오일 및 말토덱스트린 복합체를 투여하여 펙틴 보호 콜로이드를 형성하는 것일 수 있다. The step (3) is after lowering the temperature of the aqueous pectin solution to 45 to 55 ℃, for example, 46 to 54 ℃, 46 to 53 ℃, 47 to 53 ℃, 47 to 52 ℃ or 48 to 52 ℃ oil and malto It may be to form a pectin protective colloid by administering the dextrin complex.
일 구체예에 따르면, 상기 펙틴 보호 콜로이드가 형성된 수용액의 온도를 45 내지 55℃, 예를 들면, 46 내지 54℃, 46 내지 53℃, 47 내지 53℃, 47 내지 52℃ 또는 48 내지 52℃로 유지하며 80 내지 200 RPM으로 교반하며 증점제, 농축액, 감미제, 산도 조절제, 조직개량제, 영양 강화제 또는 향료를 투입하는 것을 포함할 수 있다.According to one embodiment, the temperature of the aqueous solution in which the pectin protective colloid is formed is 45 to 55 ℃, for example, 46 to 54 ℃, 46 to 53 ℃, 47 to 53 ℃, 47 to 52 ℃ or 48 to 52 ℃. While maintaining and stirring at 80 to 200 RPM, it may include adding a thickener, a concentrate, a sweetener, an acidity regulator, a tissue improver, a nutritional enhancer or a flavoring agent.
상기 증점제, 농축액, 감미제, 산도 조절제, 조직개량제, 영양 강화제 및 향료는 상기한 바와 같다.The thickener, concentrate, sweetener, acidity regulator, tissue improver, nutritional enhancer, and flavoring agent are the same as described above.
상기 오일 수분산 음료 조성물의 제조방법에서 생리활성 물질의 함량은 조성물 총 중량 기준 0.01 내지 10 중량%, 상기 오일의 함량은 조성물 총 중량 기준 0.01 내지 15 중량%, 상기 말토덱스트린의 함량은 조성물 총 중량 기준 0.05 내지 20 중량%, 및 상기 펙틴의 함량은 조성물 총 중량 기준 0.3 내지 10 중량%일 수 있다.In the method for preparing the oil-water dispersion beverage composition, the content of the physiologically active substance is 0.01 to 10% by weight based on the total weight of the composition, the content of the oil is 0.01 to 15% by weight based on the total weight of the composition, and the content of maltodextrin is the total weight of the composition Based on 0.05 to 20% by weight, and the content of the pectin may be 0.3 to 10% by weight based on the total weight of the composition.
일 양상에 따른 오일 수분산 음료 조성물 및 이의 제조 방법에 의하면, 고온 고압 살균을 버틸 수 있는 안정한 제형을 제공하여 여러 패키지에 적용할 수 있는 효과가 있다. 또한, 유화제의 사용 없이 펙틴으로 보호 콜로이드를 형성하여 오일을 분산시켜 오일에 담지된 생리활성 물질의 액상 내 결정 형성을 통한 석출을 억제하고, 섭취 시 불편함을 경감시키는 효과가 있다. 또한, 제조 공정을 단순화하여 제조 시간을 단축하고 경제성을 확보할 수 있는 효과가 있다.According to an oil-water dispersion beverage composition and a manufacturing method thereof according to an aspect, there is an effect that can be applied to various packages by providing a stable formulation capable of withstanding high-temperature and high-pressure sterilization. In addition, there is an effect of dispersing the oil by forming a protective colloid with pectin without the use of an emulsifier, thereby suppressing precipitation through crystal formation in the liquid phase of the physiologically active material supported in the oil, and alleviating discomfort during ingestion. In addition, by simplifying the manufacturing process, there is an effect of shortening the manufacturing time and securing economic feasibility.
도 1은 크릴오일 및 수불용성 말토덱스트린 복합체 제형의 안정화를 비교한 이미지이다.
도 2는 교반 시간을 단축시켜 제조한 테스트 8에서 코엔자임Q10 및 수불용성 말토덱스트린 복합체를 정제수와 혼합하기 전의 이미지이다.
도 3은 코엔자임Q10 및 수불용성 말토덱스트린 복합체를 포함하는 제형의 안정화를 비교한 이미지이다.
도 4는 코엔자임Q10 및 수불용성 말토덱스트린 복합체를 안정화 하는 제형의 이미지이다.1 is an image comparing the stabilization of krill oil and water-insoluble maltodextrin complex formulations.
2 is an image before mixing coenzyme Q10 and water-insoluble maltodextrin complex with purified water in Test 8 prepared by shortening the stirring time.
3 is an image comparing the stabilization of a formulation comprising coenzyme Q10 and a water-insoluble maltodextrin complex.
4 is an image of a formulation stabilizing the coenzyme Q10 and water-insoluble maltodextrin complex.
이하 실시예를 통하여 보다 상세하게 설명한다. 그러나, 이들 실시예는 하나 이상의 구체예를 예시적으로 설명하기 위한 것으로 본 발명의 범위가 이들 실시예에 한정되는 것은 아니다. Hereinafter, it will be described in more detail through examples. However, these examples are for illustrative purposes of one or more embodiments, and the scope of the present invention is not limited to these examples.
실시예 1, 2 및 비교예 1 내지 3. 크릴오일 및 수불용성 말토덱스트린 복합체 제조 및 상기 복합체를 안정화 하는 제형의 제조Examples 1 and 2 and Comparative Examples 1 to 3. Preparation of krill oil and water-insoluble maltodextrin complex and preparation of a formulation stabilizing the complex
크릴오일 및 수불용성 말토덱스트린 복합체를 안정화 하는 제형을 제조하기 위해 하기 표 1의 성분들을 혼합하였다.The ingredients in Table 1 below were mixed to prepare a formulation stabilizing the krill oil and water-insoluble maltodextrin complex.
구체적으로, 크릴오일 및 수불용성 말토덱스트린 복합체를 제조하기 위해 우선 수불용성 말토덱스트린을 푸드프로세서/믹서기에 투입 후 천천히 교반하면서 상기 크릴오일을 첨가하였다. 그리고 충분히 분산될 때까지 5 내지 10분 교반하여 크릴오일 및 수불용성 말토덱스트린 복합체를 제조하였다.Specifically, in order to prepare a complex of krill oil and water-insoluble maltodextrin, first, water-insoluble maltodextrin was put into a food processor/mixer, and then the krill oil was added while slowly stirring. Then, the mixture was stirred for 5 to 10 minutes until sufficiently dispersed to prepare a krill oil and water-insoluble maltodextrin complex.
그리고 크릴오일 및 수불용성 말토덱스트린 복합체를 안정화하는 제형을 제조하기 위해 우선 정제수를 80℃로 가온 교반하면서 펙틴을 첨가하여 용해시켰다. 그리고 구연산을 첨가하여 pH를 3.5 내지 4.5로 조절하였다. 그 후, 펙틴 수용액의 온도를 50℃로 낮춘 뒤 상기 크릴오일 및 수불용성 말토덱스트린 복합체를 투입하였다. 그리고 상기 용액을 50℃로 유지하면서 80 내지 200 RPM으로 교반하여 나머지 원료를 투입하여 크릴오일 및 수불용성 말토덱스트린 복합체를 안정화하는 제형을 제조하였다. 그 후 레토르트 살균을 진행하였다.And in order to prepare a formulation stabilizing the krill oil and water-insoluble maltodextrin complex, first, purified water was heated to 80° C. and stirred while pectin was added and dissolved. Then, citric acid was added to adjust the pH to 3.5 to 4.5. Thereafter, the temperature of the pectin aqueous solution was lowered to 50° C., and the krill oil and water-insoluble maltodextrin complex were added thereto. Then, the solution was stirred at 80 to 200 RPM while maintaining the temperature at 50° C., and the remaining raw materials were added to prepare a formulation stabilizing the krill oil and water-insoluble maltodextrin complex. Thereafter, retort sterilization was performed.
실시예 1, 2 및 비교예 1 내지 3의 구체적인 성분 및 함량은 하기 표 1에 나타내었다. 상기 함량은 중량%로 나타내었다.Specific components and contents of Examples 1 and 2 and Comparative Examples 1 to 3 are shown in Table 1 below. The content is expressed in wt%.
실시예 3 내지 5 및 비교예 4 내지 6. 코엔자임Q10 및 수불용성 말토덱스트린 복합체를 안정화 하는 제형의 제조Examples 3 to 5 and Comparative Examples 4 to 6. Preparation of formulations stabilizing the coenzyme Q10 and water-insoluble maltodextrin complex
먼저, 코엔자임Q10 및 수불용성 말토덱스트린 복합체를 안정화 하는 제형에서의 코엔자임Q10의 적정 함량을 선정하기 위해 코엔자임Q10의 오일에서의 분산성을 측정하였다.First, the dispersibility of coenzyme Q10 in oil was measured in order to select an appropriate content of coenzyme Q10 in a formulation for stabilizing the coenzyme Q10 and water-insoluble maltodextrin complex.
구체적으로, 코엔자임Q10을 하기 표 2와 같은 함량으로 실온에서 아르간 오일 1 g에 용해시켰다. 그 결과, 코엔자임Q10을 0.6 g 이상 첨가하면 액상의 점도가 급격히 증가함을 확인하였다.Specifically, coenzyme Q10 was dissolved in 1 g of argan oil at room temperature in an amount as shown in Table 2 below. As a result, it was confirmed that when 0.6 g or more of coenzyme Q10 was added, the viscosity of the liquid phase rapidly increased.
상기 코엔자임Q10은 건강기능식품 공전 코엔자임Q10 기준 규격에 부합하는 원료로 코엔자임Q10 함량 980 mg/1000 mg 이상인 분말 제품을 사용하였다. 코엔자임Q10 원료의 역가는 자가 분석 결과 98.26%, 공인 분석 결과 99.7%로 나타났다.The coenzyme Q10 is a raw material that meets the coenzyme Q10 standard standard for health functional foods, and a powder product with a coenzyme Q10 content of 980 mg/1000 mg or more was used. The potency of coenzyme Q10 raw material was found to be 98.26% as a result of self-analysis and 99.7% as a result of official analysis.
따라서, 코엔자임Q10의 적정 함량으로서 0.5 g을 사용하였다. 그리고 하기 표 3의 성분들을 혼합하여 코엔자임Q10 및 수불용성 말토덱스트린 복합체를 안정화 하는 제형을 제조하였다. 실시예 3 내지 5 및 비교예 4 내지 6의 구체적인 성분 및 함량은 하기 표 3에 나타내었다. 상기 함량은 중량%로 나타내었다.Therefore, 0.5 g was used as an appropriate content of coenzyme Q10. And by mixing the ingredients in Table 3 below, a formulation for stabilizing the coenzyme Q10 and water-insoluble maltodextrin complex was prepared. Specific components and contents of Examples 3 to 5 and Comparative Examples 4 to 6 are shown in Table 3 below. The content is expressed in wt%.
구체적으로, 하기와 같이 제조하였다.Specifically, it was prepared as follows.
코엔자임Q10이 담지된 오일은 실온 조건에서 코엔자임Q10을 아르간오일에 용해시켜 코엔자임Q10 오일을 제조하였다. Coenzyme Q10-supported oil was prepared by dissolving coenzyme Q10 in argan oil at room temperature.
코엔자임Q10 및 수불용성 말토덱스트린 복합체를 제조하기 위해 우선 수불용성 말토덱스트린 을 푸드프로세서/믹서기에 투입 후 천천히 교반하면서 상기 코엔자임Q10이 담지된 오일을 첨가하였다. 그리고 충분히 분산될 때까지 5 내지 10분 교반하여 코엔자임Q10 및 수불용성 말토덱스트린 복합체를 제조하였다.In order to prepare a complex of coenzyme Q10 and water-insoluble maltodextrin, first, water-insoluble maltodextrin was put into a food processor/mixer, and then the oil on which the coenzyme Q10 was supported was added while slowly stirring. Then, the mixture was stirred for 5 to 10 minutes until sufficiently dispersed to prepare a coenzyme Q10 and water-insoluble maltodextrin complex.
코엔자임Q10 및 수불용성 말토덱스트린 복합체를 안정화하는 제형을 제조하기 위해 우선 정제수를 80℃로 가온 교반하면서 펙틴을 첨가하여 용해시켰다. 그리고 구연산을 첨가하여 pH를 3.5 내지 4.5로 조절하였다. 그 후, 펙틴 수용액의 온도를 50℃로 낮춘 뒤 상기 코엔자임Q10 및 수불용성 말토덱스트린 복합체를 투입하였다. 그리고 상기 용액을 50℃로 유지하면서 80 내지 200 RPM으로 교반하여 나머지 원료를 투입하여 코엔자임Q10 및 수불용성 말토덱스트린 복합체를 안정화하는 제형을 제조하였다. 그 후, 레토르트 살균을 진행하였다.In order to prepare a formulation stabilizing the coenzyme Q10 and water-insoluble maltodextrin complex, purified water was first dissolved by adding pectin while heating and stirring to 80°C. Then, citric acid was added to adjust the pH to 3.5 to 4.5. Thereafter, the temperature of the aqueous pectin solution was lowered to 50° C., and the coenzyme Q10 and water-insoluble maltodextrin complex were added thereto. Then, the solution was stirred at 80 to 200 RPM while maintaining the temperature at 50° C., and the remaining raw materials were added to prepare a formulation stabilizing the coenzyme Q10 and water-insoluble maltodextrin complex. Thereafter, retort sterilization was performed.
실험예 1. 크릴오일 및 수불용성 말토덱스트린 복합체 제형의 안정화 평가Experimental Example 1. Evaluation of stabilization of krill oil and water-insoluble maltodextrin complex formulation
상기 실시예 1, 2 및 비교예 1 내지 3.에 따라 제조된 크릴오일 및 수불용성 말토덱스트린 복합체 제형의 안정화를 비교하였다. 이를 표 4 및 도 1에 나타내었다.The stabilization of the krill oil and water-insoluble maltodextrin complex formulations prepared according to Examples 1 and 2 and Comparative Examples 1 to 3. was compared. This is shown in Table 4 and FIG. 1 .
구체적으로, 상기 실시예 1 및 실시예 2에 따른 제형은 오일의 분리가 발생하지 않음을 확인하였다. 또한, 실시예 1에 따른 제형의 경우, 점도 및 식감 면에서 가장 적합함을 확인하였다. Specifically, it was confirmed that the formulations according to Examples 1 and 2 did not cause oil separation. In addition, in the case of the formulation according to Example 1, it was confirmed that the most suitable in terms of viscosity and texture.
상기 비교예 1에 따른 제형에서는 오일 분리가 발생함을 확인하였다. 구체적으로, 수불용성 말토덱스트린 및 오일의 비율이 적정 범위를 넘어 오일이 포집되지 못하고 방출되어 분리가 형성됨을 확인하였다.It was confirmed that oil separation occurred in the formulation according to Comparative Example 1. Specifically, it was confirmed that the ratio of water-insoluble maltodextrin and oil exceeded an appropriate range, and oil was not captured and released, thereby forming separation.
상기 비교예 2에 따른 제형에서는 상기 복합체가 셀룰로오스 층 내에 안정하게 안착되었지만, 셀룰로오스 층이 가라앉는 것을 확인하였다. In the formulation according to Comparative Example 2, although the composite was stably seated in the cellulose layer, it was confirmed that the cellulose layer subsided.
상기 비교예 3에 따른 제형에서는 펙틴의 함량이 줄었음에도 불구하고 오일 분리가 발생하지 않음을 확인하였다. 그러나, 펙틴의 함량이 적어 충분히 보호콜로이드로 감싸지 못하고, 침전되는 현상이 발생함을 확인하였다.In the formulation according to Comparative Example 3, it was confirmed that oil separation did not occur even though the content of pectin was reduced. However, it was confirmed that the content of pectin was small, so that it could not be sufficiently wrapped with a protective colloid, and a phenomenon of precipitation occurred.
이러한 결과는 말토덱스트린 및 오일의 비율이 제형의 안정성에 중요한 영향을 미치고, 펙틴이 크릴오일 및 수불용성 말토덱스트린 복합체를 안정화시켜주어, 유화제 없이도 제형이 안정화될 수 있음을 의미한다.These results indicate that the ratio of maltodextrin and oil has an important effect on the stability of the formulation, and pectin stabilizes the krill oil and water-insoluble maltodextrin complex, so that the formulation can be stabilized without an emulsifier.
도 1은 크릴오일 및 수불용성 말토덱스트린 복합체 제형의 안정화를 비교한 이미지이다.1 is an image comparing the stabilization of krill oil and water-insoluble maltodextrin complex formulation.
도 1에 나타낸 바와 같이, 유화제를 포함하지 않는 크릴오일 및 수불용성 말토덱스트린 복합체 제형이 안정함을 확인하였다.As shown in FIG. 1 , it was confirmed that the formulation of the krill oil and water-insoluble maltodextrin complex containing no emulsifier was stable.
실험예 2. 코엔자임Q10 오일의 수불용성 말토덱스트린 복합체에서의 분산 안정성 측정Experimental Example 2. Measurement of dispersion stability in water-insoluble maltodextrin complex of coenzyme Q10 oil
코엔자임Q10 0.5 g을 아르간 오일 1 g에 용해시켜 코엔자임Q10 혼합 오일을 제조하였다. 그리고, 수불용성 말토덱스트린을 푸드프로세서에 투입 후 천천히 교반하면서 상기 코엔자임Q10 오일을 하기 표 5와 같은 함량으로 첨가하였다. 그리고 충분히 분산될 때까지 5 내지 10분동안 교반하였다. 교반한 코엔자임Q10 및 수불용성 말토덱스트린 복합체를 물에 5 내지 10분 동안 교반하여 혼합한 뒤 2시간 동안 분리 현상을 관측하였다. 0.5 g of coenzyme Q10 was dissolved in 1 g of argan oil to prepare a coenzyme Q10 mixed oil. Then, after adding water-insoluble maltodextrin to the food processor, the coenzyme Q10 oil was added in an amount as shown in Table 5 below while slowly stirring. Then, the mixture was stirred for 5 to 10 minutes until fully dispersed. The stirred coenzyme Q10 and water-insoluble maltodextrin complex was stirred and mixed in water for 5 to 10 minutes, and then the separation was observed for 2 hours.
테스트 6 및 7에서는 사용하기 용이한 고운 가루가 형섬됨을 확인하였다. 이는 말토덱스트린 : 오일의 비율이 1.5 내지 15 : 1인 경우 코엔자임Q10 오일의 수불용성 말토덱스트린 복합체에서의 분산 안정성이 뛰어남을 의미한다.In tests 6 and 7, it was confirmed that an easy-to-use fine powder was formed. This means that when the ratio of maltodextrin: oil is 1.5 to 15: 1, dispersion stability of coenzyme Q10 oil in the water-insoluble maltodextrin complex is excellent.
테스트 8에서는 코엔자임Q10 혼합 오일이 수불용성 말토덱스트린 내 다 흡수되었으나 분말들이 촉촉하게 뭉쳐져 있음을 확인하였다, In Test 8, it was confirmed that the coenzyme Q10 blended oil was fully absorbed in the water-insoluble maltodextrin, but the powders were moistly agglomerated.
테스트 9 내지 11에서는 코엔자임Q10 혼합 오일이 수불용성 말토덱스트린 내 전부 포집되지 못하고 새어 나오는 것을 확인하였다. In tests 9 to 11, it was confirmed that the coenzyme Q10 mixed oil leaked out without being fully captured in the water-insoluble maltodextrin.
또한, 상기 테스트 10 및 11에서는 코엔자임Q10 및 수불용성 말토덱스트린 복합체를 물에 혼합하여 교반하는 동안 오일의 분리 현상이 발생함을 확인하였고, 2시간 경과 후 테스트 6 내지 11에서 모두 오일이 분리됨을 확인하였다. In addition, in Tests 10 and 11, it was confirmed that oil separation occurred while mixing coenzyme Q10 and water-insoluble maltodextrin complex in water and stirring, and it was confirmed that all oils were separated in Tests 6 to 11 after 2 hours did.
또한, 교반 시간이 충분하지 않을 경우 오일의 분산 균일성이 떨어짐을 확인하였고, 이를 도 2에 나타내었다.In addition, it was confirmed that the dispersion uniformity of the oil was deteriorated when the stirring time was not sufficient, which is shown in FIG. 2 .
도 2는 교반 시간을 단축시켜 제조한 테스트 8에서 코엔자임Q10 및 수불용성 말토덱스트린 복합체를 정제수와 혼합하기 전의 이미지이다.2 is an image before mixing coenzyme Q10 and water-insoluble maltodextrin complex with purified water in Test 8 prepared by shortening the stirring time.
실험예 3. 코엔자임Q10 및 수불용성 말토덱스트린 복합체의 제형의 안정화 비교Experimental Example 3. Comparison of stabilization of formulations of coenzyme Q10 and water-insoluble maltodextrin complex
실시예 3 내지 5 및 비교예 4 내지 6에 따라 코엔자임Q10 및 수불용성 말토덱스트린 복합체의 제형을 제조하여 안정화를 비교하였다. 이를 도 3에 나타내었다.Formulations of coenzyme Q10 and water-insoluble maltodextrin complex were prepared according to Examples 3 to 5 and Comparative Examples 4 to 6 to compare stabilization. This is shown in FIG. 3 .
구체적으로, 실시예 3 내지 5의 제형은 코엔자임Q10 및 수불용성 말토덱스트린 복합체가 모두 안정하게 분산됨을 확인하였다. Specifically, the formulations of Examples 3 to 5 confirmed that both coenzyme Q10 and water-insoluble maltodextrin complex were stably dispersed.
펙틴이 불포함된 비교예 4의 제형은 코엔자임Q10 및 수불용성 말토덱스트린 복합체를 안정하게 하지 못함을 확인하였다. 또한, 비교예 5의 제형은 코엔자임Q10 및 수불용성 말토덱스트린 복합체의 침전이 발생함을 확인하였다. 비교예 6의 제형은 제조 직후에는 양호하나 시간이 지남에 따라 오일의 분리가 심해짐을 확인하였다. It was confirmed that the formulation of Comparative Example 4 without pectin did not stabilize the coenzyme Q10 and water-insoluble maltodextrin complex. In addition, it was confirmed that the formulation of Comparative Example 5 caused precipitation of coenzyme Q10 and water-insoluble maltodextrin complex. The formulation of Comparative Example 6 was good immediately after preparation, but it was confirmed that the separation of oil worsened over time.
이러한 결과는 말토덱스트린 및 오일의 비율이 제형의 안정성에 영향을 미치고, 펙틴을 총 조성물 대비 0.3 중량% 이상으로 포함하지 않으면, 제형이 불안정해짐을 의미한다. This result means that the ratio of maltodextrin and oil affects the stability of the formulation, and if pectin is not included in an amount of 0.3% by weight or more relative to the total composition, the formulation becomes unstable.
도 3은 코엔자임Q10 및 수불용성 말토덱스트린 복합체를 포함하는 제형의 안정화를 비교한 이미지이다.3 is an image comparing the stabilization of a formulation comprising coenzyme Q10 and a water-insoluble maltodextrin complex.
실험예 4. 코엔자임Q10 및 수불용성 말토덱스트린 복합체를 안정화 하는 제형의 살균 안정성 및 역가 확인Experimental Example 4. Confirmation of sterilization stability and potency of formulations stabilizing coenzyme Q10 and water-insoluble maltodextrin complex
실시예 4에 따른 제형의 살균 안정성 확인하기 위해, 상기 제형을 살균하였다. 구체적으로, PP/PE 10 내지 20 ML 스틱을 이용하여 110 ℃에서 25분 동안 레토르트 살균을 진행하였다. 이후 상온에서 1개월 동안 방치하고, 흔들지 않고 패키지를 그대로 개봉하여 패키지에 충진된 제형을 관찰하였다. 상기 제형은 성상에서 변화를 보이지 않았고, 그 결과를 도 4에 나타내었다.In order to confirm the sterilization stability of the formulation according to Example 4, the formulation was sterilized. Specifically, retort sterilization was performed at 110° C. for 25 minutes using a PP/PE 10 to 20 ML stick. After that, it was left at room temperature for 1 month, and the package was opened without shaking to observe the formulation filled in the package. The formulation showed no change in properties, and the results are shown in FIG. 4 .
도 4는 코엔자임Q10 및 수불용성 말토덱스트린 복합체를 안정화 하는 제형의 이미지이다.4 is an image of a formulation stabilizing the coenzyme Q10 and water-insoluble maltodextrin complex.
도 4에 나타낸 바와 같이, 코엔자임Q10 및 수불용성 말토덱스트린 복합체를 안정화 하는 제형은 시간이 흘러도 안정함 유지하는 것을 알 수 있었다.As shown in FIG. 4 , it was found that the formulation stabilizing the coenzyme Q10 and water-insoluble maltodextrin complex remained stable over time.
또한, 실시예 4에 따른 제형의 안정성을 식약처에서 고시한 건강기능식품 공전 시험법에 따라 분석하여 시간이 흘러도 역가가 유지됨을 확인하였고, 그 결과를 표 6에 나타내었다. In addition, the stability of the formulation according to Example 4 was analyzed according to the public health functional food test method announced by the Ministry of Food and Drug Safety, and it was confirmed that the potency was maintained over time, and the results are shown in Table 6.
Claims (18)
조성물 총 중량에 대하여 상기 오일은 0.01 내지 15 중량%, 상기 말토덱스트린은 0.05 내지 20 중량%, 및 상기 펙틴은 0.3 내지 10 중량%로 포함되고,
상기 말토덱스트린 및 오일은 1.5 내지 15 : 1의 중량비로 포함되며,
상기 오일은 식용 오일인 것인, 오일 수분산 음료 조성물.oil, including maltodextrin and pectin;
Based on the total weight of the composition, the oil is contained in an amount of 0.01 to 15% by weight, the maltodextrin is 0.05 to 20% by weight, and the pectin is 0.3 to 10% by weight,
The maltodextrin and oil are included in a weight ratio of 1.5 to 15: 1,
The oil is an edible oil, an oil-dispersed beverage composition.
생리활성 물질을 더 포함하고
상기 생리활성 물질은 코엔자임Q10, 레티놀 (retinol), 토코페롤(tocopherol), 아스타잔틴(astaxanthin), 루테인(lutein), 오메가3, 감마-리놀렌산(γ-linolenic acid), 옥타코사놀(octacosanol), 알콕시글리세롤(alkylglycerol), 공액리놀렌산(conjugated linoleic acid)) 및 파이토케미칼(phytochemical)로 이루어진 군으로부터 선택되는 하나 이상인 것인, 오일 수분산 음료 조성물.The method according to claim 1,
Contains more bioactive substances
The physiologically active substance is coenzyme Q10, retinol, tocopherol, astaxanthin, lutein, omega 3, gamma-linolenic acid, octacosanol, alkoxyglycerol. (alkylglycerol), conjugated linoleic acid (conjugated linoleic acid)) and phytochemicals (phytochemical) will be at least one selected from the group consisting of, oil-dispersed beverage composition.
상기 식용 오일은 동물성 오일 또는 식물성 오일인, 오일 수분산 음료 조성물.The method according to claim 1,
The edible oil is an animal oil or a vegetable oil, oil dispersion beverage composition.
상기 식물성 오일은 아르간 오일, 아마란스 오일, 살구씨 오일, 아티초크 오일, 바바수야자유, 보르네오 수지 넛(borneo tallow nut) 오일, 조롱박유, 버팔로 조롱박 오일, 보리지 오일, 아마씨유, 카롭 열매 오일, 양귀비 씨 오일, 벤(ben) 오일 참깨 오일, 버섯 오일, 헤이즐넛 오일, 홍화유, 해바라기유, 카놀라유, 땅콩유, 대두유, 쌀겨 오일, 유채 오일, 팜 커넬 오일, 면실유, 잇꽃유, 옥수수유, 팜유, 올리브유, 코코넛유, 코코아유, 달맞이꽃 오일, 팜 커널유, 아몬드유, 호호바유, 아보카도유, 호두 오일 및 캐스터 오일로 이루어진 군으로부터 선택되는 하나 이상인 것인, 오일 수분산 음료 조성물.5. The method according to claim 4,
The vegetable oil includes argan oil, amaranth oil, apricot seed oil, artichoke oil, babassu oil, borneo tallow nut oil, gourd oil, buffalo gourd oil, borage oil, linseed oil, carob fruit oil, Poppy seed oil, ben oil, sesame oil, mushroom oil, hazelnut oil, safflower oil, sunflower oil, canola oil, peanut oil, soybean oil, rice bran oil, rapeseed oil, palm kernel oil, cottonseed oil, safflower oil, corn oil, palm oil, Olive oil, coconut oil, cocoa oil, evening primrose oil, palm kernel oil, almond oil, jojoba oil, avocado oil, walnut oil, and at least one selected from the group consisting of castor oil, oil-dispersed beverage composition.
상기 동물성 오일은 크릴오일, 스쿠알렌, 스쿠알란, 난황오일, 밍크오일, 우지, 돈지, 양지, 계유, 번데기오일 및 생선오일로 이루어진 군으로부터 선택되는 하나 이상인 것인, 오일 수분산 음료 조성물.5. The method according to claim 4,
The animal oil is at least one selected from the group consisting of krill oil, squalene, squalane, egg yolk oil, mink oil, beef tallow, lard, brisket, chicken oil, pupa oil and fish oil, oil-dispersed beverage composition.
상기 말토덱스트린은 수불용성 말토덱스트린인, 오일 수분산 음료 조성물.The method according to claim 1,
The maltodextrin is water-insoluble maltodextrin, an oily water dispersion beverage composition.
증점제를 추가로 더 포함하는, 오일 수분산 음료 조성물.The method according to claim 1,
An oil-dispersed beverage composition further comprising a thickener.
상기 증점제는 한천, 산탄검, 로커스트빈검, 젤라틴, 카라기난, 구아검, 젤란검, 알긴산, 펙틴, 아라비아검, 카르복시 메틸셀룰로오스, 메틸셀룰로오스, 헤미 셀룰로오스 및 셀룰로오스로 이루어진 군으로부터 선택된 하나 이상인 것인, 오일 수분산 음료 조성물.9. The method of claim 8,
The thickener is at least one selected from the group consisting of agar, xanthan gum, locust bean gum, gelatin, carrageenan, guar gum, gellan gum, alginic acid, pectin, gum arabic, carboxymethylcellulose, methylcellulose, hemicellulose and cellulose, oil A water-dispersed beverage composition.
조성물 총 중량 대비 0.01 내지 10 중량%의 생리활성물질을 포함하는, 오일 수분산 음료 조성물.3. The method according to claim 2,
An oil-dispersed beverage composition comprising 0.01 to 10% by weight of a physiologically active substance based on the total weight of the composition.
상기 오일 수분산 음료 조성물은 유화제를 포함하지 않는, 오일 수분산 음료 조성물.The method according to claim 1,
The oil-dispersed beverage composition does not contain an emulsifier, an oil-water-dispersed beverage composition.
(2) 펙틴(pectin) 수용액을 준비하는 단계; 및
(3) 상기 오일 및 말토덱스트린 복합체를 펙틴 수용액에 분산하여 펙틴 보호 콜로이드를 형성하는 단계를 포함하고,
조성물 총 중량에 대하여 상기 오일은 0.01 내지 15 중량%, 상기 말토덱스트린은 0.05 내지 20 중량%, 및 상기 펙틴은 0.3 내지 10 중량%로 포함되며,
상기 말토덱스트린 및 오일은 1.5 내지 15 : 1의 중량비로 포함되고,
상기 오일은 식용 오일인 것인, 오일 수분산 음료 조성물의 제조방법.(1) dispersing the oil in maltodextrin to prepare an oil and maltodextrin complex;
(2) preparing an aqueous solution of pectin; and
(3) dispersing the oil and maltodextrin complex in an aqueous pectin solution to form a pectin protective colloid,
Based on the total weight of the composition, 0.01 to 15% by weight of the oil, 0.05 to 20% by weight of the maltodextrin, and 0.3 to 10% by weight of the pectin,
The maltodextrin and oil are included in a weight ratio of 1.5 to 15: 1,
The oil is an edible oil, the method for producing an oil-dispersed beverage composition.
상기 단계 (1)의 오일은 생리활성 물질이 담지된 오일이고,
상기 생리활성 물질은 코엔자임Q10, 레티놀(retinol), 토코페롤(tocopherol), 아스타잔틴(astaxanthin), 루테인(lutein), 오메가3, 감마-리놀렌산(γ-linolenic acid), 옥타코사놀(octacosanol), 알콕시글리세롤(alkylglycerol), 공액리놀렌산(conjugated linoleic acid)) 및 파이토케미칼(phytochemical)로 이루어진 군으로부터 선택되는 하나 이상인 것인, 오일 수분산 음료 조성물의 제조방법. 15. The method of claim 14,
The oil of step (1) is an oil on which a physiologically active substance is supported,
The physiologically active substance is coenzyme Q10, retinol, tocopherol, astaxanthin, lutein, omega 3, gamma-linolenic acid, octacosanol, alkoxyglycerol. (alkylglycerol), conjugated linoleic acid (conjugated linoleic acid) and phytochemical (phytochemical) will be at least one selected from the group consisting of, a method for producing an oil-dispersed beverage composition.
상기 단계 (3)의 펙틴 수용액은 상기 펙틴 수용액에 산도 조절제를 첨가하여 pH 3 내지 5로 조절된 펙틴 수용액인, 오일 수분산 음료 조성물의 제조방법. 15. The method of claim 14,
The pectin aqueous solution of step (3) is a pectin aqueous solution adjusted to pH 3 to 5 by adding an acidity control agent to the pectin aqueous solution, a method for producing an oil-water dispersion beverage composition.
상기 펙틴 보호 콜로이드가 형성된 수용액에 증점제를 추가로 투입하는 단계를 추가로 더 포함하는, 오일 수분산 음료 조성물의 제조방법.15. The method of claim 14,
Further comprising the step of further adding a thickener to the aqueous solution in which the pectin protective colloid is formed, the method for producing an oil-water dispersion beverage composition.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020210161588A KR102431821B1 (en) | 2021-11-22 | 2021-11-22 | A beverage composition comprising oil, maltodextrin and pectin and manufacturing method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020210161588A KR102431821B1 (en) | 2021-11-22 | 2021-11-22 | A beverage composition comprising oil, maltodextrin and pectin and manufacturing method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
KR102431821B1 true KR102431821B1 (en) | 2022-08-12 |
KR102431821B9 KR102431821B9 (en) | 2023-04-12 |
Family
ID=82803648
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020210161588A KR102431821B1 (en) | 2021-11-22 | 2021-11-22 | A beverage composition comprising oil, maltodextrin and pectin and manufacturing method thereof |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102431821B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116998721A (en) * | 2023-08-11 | 2023-11-07 | 汤臣倍健股份有限公司 | Preparation method of krill oil polycosanol soft capsule |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019066068A1 (en) * | 2017-09-29 | 2019-04-04 | 富士フイルム株式会社 | Oil-in-water type emulsified composition, and food and beverage containing same |
KR20200048477A (en) * | 2018-10-30 | 2020-05-08 | (주)아모레퍼시픽 | Liquid composition with excellent heat stability |
KR20210079443A (en) * | 2019-12-19 | 2021-06-30 | 주식회사 디네이쳐바이오랩스 | Drink Composition comprising Omega―3 fatty acid and Method of preparing the same |
-
2021
- 2021-11-22 KR KR1020210161588A patent/KR102431821B1/en active IP Right Grant
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019066068A1 (en) * | 2017-09-29 | 2019-04-04 | 富士フイルム株式会社 | Oil-in-water type emulsified composition, and food and beverage containing same |
KR20200048477A (en) * | 2018-10-30 | 2020-05-08 | (주)아모레퍼시픽 | Liquid composition with excellent heat stability |
KR20210079443A (en) * | 2019-12-19 | 2021-06-30 | 주식회사 디네이쳐바이오랩스 | Drink Composition comprising Omega―3 fatty acid and Method of preparing the same |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116998721A (en) * | 2023-08-11 | 2023-11-07 | 汤臣倍健股份有限公司 | Preparation method of krill oil polycosanol soft capsule |
Also Published As
Publication number | Publication date |
---|---|
KR102431821B9 (en) | 2023-04-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4422726B2 (en) | Satiety food composition | |
JP5147239B2 (en) | Coenzyme Q10-containing emulsion composition | |
US20090181114A1 (en) | Chia seed beverage and related method | |
EP2238843A1 (en) | Compositions of fat-soluble active ingredients containing protein-polysaccharide conjugates | |
CN101394756A (en) | Food and beverage products with improved taste impressions | |
JP2007503822A (en) | Satiety food composition | |
KR20050083894A (en) | Muscle building preparation | |
WO2013085059A1 (en) | Method for producing nutritional composition | |
CN109527560A (en) | The liquid nutritional compositions rich in energy with improved organoleptic properties | |
TWI434659B (en) | Induced viscosity nutritional emulsions comprising a carbohydrate-surfactant complex | |
KR101277367B1 (en) | Novel compositions comprising carotenoids | |
KR102431821B1 (en) | A beverage composition comprising oil, maltodextrin and pectin and manufacturing method thereof | |
CN110650636A (en) | Encapsulated nutritional and pharmaceutical compositions | |
EP3170406B1 (en) | Gel-form emulsified food | |
JP3781157B2 (en) | Powdered nutritional composition for those with difficulty swallowing | |
JP2018171068A (en) | Viscous nutritive composition | |
JP6061263B2 (en) | Gel-like food and method for producing the same | |
EP3494801A1 (en) | Jelly beverage and method for manufacturing jelly beverage | |
JP2004008165A (en) | Gelatinous food containing medium-chain fat | |
KR102359555B1 (en) | Drink Composition comprising Omega―3 fatty acid and Method of preparing the same | |
WO2018179953A1 (en) | High-calorie nutritional composition, and package | |
AU2011211461B2 (en) | Chia seed composition | |
JP2006191904A (en) | Gelling agent preparation | |
EP3582631B1 (en) | Method of preparing a dried hydrogel co-gel | |
KR20160058475A (en) | Composition for Ice Cakes and Manufacturing Method Thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
G170 | Re-publication after modification of scope of protection [patent] |